CN111096416A - Diet-depriving composition for weight-losing meal replacement and preparation method thereof - Google Patents
Diet-depriving composition for weight-losing meal replacement and preparation method thereof Download PDFInfo
- Publication number
- CN111096416A CN111096416A CN201911366214.XA CN201911366214A CN111096416A CN 111096416 A CN111096416 A CN 111096416A CN 201911366214 A CN201911366214 A CN 201911366214A CN 111096416 A CN111096416 A CN 111096416A
- Authority
- CN
- China
- Prior art keywords
- powder
- extract
- temperature
- preparing
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 92
- 235000012054 meals Nutrition 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 239000000843 powder Substances 0.000 claims abstract description 180
- 239000000284 extract Substances 0.000 claims abstract description 116
- 239000003094 microcapsule Substances 0.000 claims abstract description 108
- 235000005911 diet Nutrition 0.000 claims abstract description 82
- 230000037213 diet Effects 0.000 claims abstract description 82
- 239000003814 drug Substances 0.000 claims abstract description 82
- 235000013339 cereals Nutrition 0.000 claims abstract description 56
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 50
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 50
- 229940088594 vitamin Drugs 0.000 claims abstract description 46
- 229930003231 vitamin Natural products 0.000 claims abstract description 46
- 235000013343 vitamin Nutrition 0.000 claims abstract description 46
- 239000011782 vitamin Substances 0.000 claims abstract description 46
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 39
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 38
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 37
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 37
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 37
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 34
- 239000011707 mineral Substances 0.000 claims abstract description 34
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 30
- 241000196324 Embryophyta Species 0.000 claims abstract description 25
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 235000010987 pectin Nutrition 0.000 claims abstract description 25
- 239000001814 pectin Substances 0.000 claims abstract description 25
- 229920001277 pectin Polymers 0.000 claims abstract description 25
- 240000007594 Oryza sativa Species 0.000 claims abstract description 19
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 19
- 235000009566 rice Nutrition 0.000 claims abstract description 19
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 15
- 239000001259 polydextrose Substances 0.000 claims abstract description 15
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 15
- 229940035035 polydextrose Drugs 0.000 claims abstract description 15
- 239000004386 Erythritol Substances 0.000 claims abstract description 13
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019414 erythritol Nutrition 0.000 claims abstract description 13
- 229940009714 erythritol Drugs 0.000 claims abstract description 13
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 13
- 244000134552 Plantago ovata Species 0.000 claims abstract description 11
- 235000003421 Plantago ovata Nutrition 0.000 claims abstract description 11
- 239000010903 husk Substances 0.000 claims abstract description 9
- 239000004519 grease Substances 0.000 claims abstract description 7
- 239000002131 composite material Substances 0.000 claims description 89
- 238000002156 mixing Methods 0.000 claims description 84
- 238000000034 method Methods 0.000 claims description 68
- 238000000605 extraction Methods 0.000 claims description 64
- 150000004676 glycans Chemical class 0.000 claims description 64
- 229920001282 polysaccharide Polymers 0.000 claims description 64
- 239000005017 polysaccharide Substances 0.000 claims description 64
- 239000003921 oil Substances 0.000 claims description 54
- 235000019198 oils Nutrition 0.000 claims description 54
- 238000007873 sieving Methods 0.000 claims description 52
- 239000002994 raw material Substances 0.000 claims description 51
- 238000001694 spray drying Methods 0.000 claims description 44
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 43
- 235000018102 proteins Nutrition 0.000 claims description 36
- 241001506047 Tremella Species 0.000 claims description 34
- 238000000926 separation method Methods 0.000 claims description 34
- 235000010755 mineral Nutrition 0.000 claims description 33
- 238000001035 drying Methods 0.000 claims description 32
- 230000001976 improved effect Effects 0.000 claims description 32
- 230000004580 weight loss Effects 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 229920002774 Maltodextrin Polymers 0.000 claims description 31
- 239000005913 Maltodextrin Substances 0.000 claims description 31
- 229940035034 maltodextrin Drugs 0.000 claims description 31
- 239000000463 material Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 230000001603 reducing effect Effects 0.000 claims description 28
- -1 compound vitamin Chemical class 0.000 claims description 27
- 238000005516 engineering process Methods 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 27
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 25
- 235000007317 Avena nuda Nutrition 0.000 claims description 25
- 240000007054 Avena nuda Species 0.000 claims description 25
- 240000005979 Hordeum vulgare Species 0.000 claims description 25
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 25
- 239000000661 sodium alginate Substances 0.000 claims description 25
- 235000010413 sodium alginate Nutrition 0.000 claims description 25
- 229940005550 sodium alginate Drugs 0.000 claims description 25
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 24
- 235000017803 cinnamon Nutrition 0.000 claims description 24
- 229960000292 pectin Drugs 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 24
- 230000035784 germination Effects 0.000 claims description 21
- 238000005342 ion exchange Methods 0.000 claims description 21
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 20
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 20
- 239000000377 silicon dioxide Substances 0.000 claims description 20
- 235000012239 silicon dioxide Nutrition 0.000 claims description 20
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 19
- 229920000858 Cyclodextrin Polymers 0.000 claims description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 18
- 244000062793 Sorghum vulgare Species 0.000 claims description 18
- 239000011162 core material Substances 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 18
- 238000007710 freezing Methods 0.000 claims description 18
- 230000008014 freezing Effects 0.000 claims description 18
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 18
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims description 18
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 18
- 239000002245 particle Substances 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 16
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 15
- 239000000194 fatty acid Substances 0.000 claims description 15
- 229930195729 fatty acid Natural products 0.000 claims description 15
- 230000002829 reductive effect Effects 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 15
- 244000302512 Momordica charantia Species 0.000 claims description 14
- 235000009811 Momordica charantia Nutrition 0.000 claims description 14
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 14
- 239000010491 poppyseed oil Substances 0.000 claims description 14
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 13
- 241000198694 Passiflora pallida Species 0.000 claims description 13
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 13
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 13
- 239000006185 dispersion Substances 0.000 claims description 13
- 238000000227 grinding Methods 0.000 claims description 13
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims description 12
- 244000130270 Fagopyrum tataricum Species 0.000 claims description 12
- 108010059820 Polygalacturonase Proteins 0.000 claims description 12
- 229930006000 Sucrose Natural products 0.000 claims description 12
- 230000008901 benefit Effects 0.000 claims description 12
- 239000011666 cyanocobalamin Substances 0.000 claims description 12
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 12
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 12
- 239000011724 folic acid Substances 0.000 claims description 12
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 12
- 238000005374 membrane filtration Methods 0.000 claims description 12
- 229940092258 rosemary extract Drugs 0.000 claims description 12
- 235000020748 rosemary extract Nutrition 0.000 claims description 12
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 12
- 239000005720 sucrose Substances 0.000 claims description 12
- 229960004793 sucrose Drugs 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 11
- 238000004945 emulsification Methods 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 229940106134 krill oil Drugs 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 102000011632 Caseins Human genes 0.000 claims description 10
- 108010076119 Caseins Proteins 0.000 claims description 10
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 10
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 10
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 10
- 235000013312 flour Nutrition 0.000 claims description 10
- 229960000304 folic acid Drugs 0.000 claims description 10
- 235000019152 folic acid Nutrition 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 10
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 10
- 239000001095 magnesium carbonate Substances 0.000 claims description 10
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 10
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 10
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 10
- 238000012545 processing Methods 0.000 claims description 10
- 229960000342 retinol acetate Drugs 0.000 claims description 10
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 10
- 239000011770 retinyl acetate Substances 0.000 claims description 10
- 235000019173 retinyl acetate Nutrition 0.000 claims description 10
- 229960002477 riboflavin Drugs 0.000 claims description 10
- 235000019192 riboflavin Nutrition 0.000 claims description 10
- 239000002151 riboflavin Substances 0.000 claims description 10
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 10
- 229960005055 sodium ascorbate Drugs 0.000 claims description 10
- 229940080237 sodium caseinate Drugs 0.000 claims description 10
- 239000006188 syrup Substances 0.000 claims description 10
- 235000020357 syrup Nutrition 0.000 claims description 10
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 10
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 10
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 10
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 10
- 239000011670 zinc gluconate Substances 0.000 claims description 10
- 229960000306 zinc gluconate Drugs 0.000 claims description 10
- 235000011478 zinc gluconate Nutrition 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 241000219784 Sophora Species 0.000 claims description 9
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 9
- 230000001804 emulsifying effect Effects 0.000 claims description 9
- 229940088598 enzyme Drugs 0.000 claims description 9
- 235000019713 millet Nutrition 0.000 claims description 9
- 229960003512 nicotinic acid Drugs 0.000 claims description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims description 9
- 239000011664 nicotinic acid Substances 0.000 claims description 9
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 9
- 238000011112 process operation Methods 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 9
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 9
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 9
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 9
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 9
- 238000005070 sampling Methods 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 244000077995 Coix lacryma jobi Species 0.000 claims description 8
- 240000004922 Vigna radiata Species 0.000 claims description 8
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 8
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 8
- 235000012015 potatoes Nutrition 0.000 claims description 8
- 229960001866 silicon dioxide Drugs 0.000 claims description 8
- XJECNSWAHCMYNZ-UHFFFAOYSA-N C=C.[Fe].[Na] Chemical group C=C.[Fe].[Na] XJECNSWAHCMYNZ-UHFFFAOYSA-N 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 7
- 235000018365 Momordica dioica Nutrition 0.000 claims description 7
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 7
- 108090000631 Trypsin Proteins 0.000 claims description 7
- 102000004142 Trypsin Human genes 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 claims description 7
- 238000007670 refining Methods 0.000 claims description 7
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 7
- 239000012588 trypsin Substances 0.000 claims description 7
- 239000011647 vitamin D3 Substances 0.000 claims description 7
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 6
- 241000911175 Citharexylum caudatum Species 0.000 claims description 6
- 241000721662 Juniperus Species 0.000 claims description 6
- 244000052616 bacterial pathogen Species 0.000 claims description 6
- 108010019077 beta-Amylase Proteins 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 6
- 239000000177 juniperus communis l. berry Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 239000011261 inert gas Substances 0.000 claims description 5
- 238000006864 oxidative decomposition reaction Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 4
- 235000015266 Plantago major Nutrition 0.000 claims description 4
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 4
- 230000009849 deactivation Effects 0.000 claims description 4
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 4
- 230000002572 peristaltic effect Effects 0.000 claims description 4
- 230000001863 plant nutrition Effects 0.000 claims description 4
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 claims description 3
- 241000209761 Avena Species 0.000 claims description 3
- 235000007319 Avena orientalis Nutrition 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 3
- 108090000637 alpha-Amylases Proteins 0.000 claims description 3
- 102000004139 alpha-Amylases Human genes 0.000 claims description 3
- 229940024171 alpha-amylase Drugs 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 238000004332 deodorization Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- NNXNKLLWTKSODZ-UHFFFAOYSA-N [acetyloxy-[2-(diacetyloxyamino)ethyl]amino] acetate;iron;sodium Chemical compound [Na].[Fe].CC(=O)ON(OC(C)=O)CCN(OC(C)=O)OC(C)=O NNXNKLLWTKSODZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 241000239370 Euphausia superba Species 0.000 claims 2
- 240000005561 Musa balbisiana Species 0.000 claims 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims 1
- 235000011613 Pinus brutia Nutrition 0.000 claims 1
- 241000018646 Pinus brutia Species 0.000 claims 1
- 239000005927 Pyriproxyfen Substances 0.000 claims 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 description 61
- 235000019197 fats Nutrition 0.000 description 31
- 235000016709 nutrition Nutrition 0.000 description 30
- 208000008589 Obesity Diseases 0.000 description 25
- 235000020824 obesity Nutrition 0.000 description 24
- 230000037221 weight management Effects 0.000 description 22
- 235000013305 food Nutrition 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 239000010410 layer Substances 0.000 description 18
- 235000013325 dietary fiber Nutrition 0.000 description 17
- 230000006870 function Effects 0.000 description 16
- 230000035764 nutrition Effects 0.000 description 16
- 230000001965 increasing effect Effects 0.000 description 12
- 230000001105 regulatory effect Effects 0.000 description 12
- 235000000346 sugar Nutrition 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 11
- 230000036541 health Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 235000019627 satiety Nutrition 0.000 description 11
- 230000036186 satiety Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 239000003053 toxin Substances 0.000 description 10
- 231100000765 toxin Toxicity 0.000 description 10
- 230000006378 damage Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 8
- 229930003944 flavone Natural products 0.000 description 8
- 150000002212 flavone derivatives Chemical class 0.000 description 8
- 235000011949 flavones Nutrition 0.000 description 8
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 8
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 230000003750 conditioning effect Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 7
- 235000013406 prebiotics Nutrition 0.000 description 7
- 206010067484 Adverse reaction Diseases 0.000 description 6
- 230000006838 adverse reaction Effects 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 235000005686 eating Nutrition 0.000 description 6
- 235000003642 hunger Nutrition 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 206010033307 Overweight Diseases 0.000 description 5
- 210000000577 adipose tissue Anatomy 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000002651 drug therapy Methods 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 208000017667 Chronic Disease Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 241001127637 Plantago Species 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 238000009207 exercise therapy Methods 0.000 description 4
- 235000020828 fasting Nutrition 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000006286 nutrient intake Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 208000017701 Endocrine disease Diseases 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 208000013016 Hypoglycemia Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 244000046101 Sophora japonica Species 0.000 description 3
- 235000010586 Sophora japonica Nutrition 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 235000019577 caloric intake Nutrition 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 230000006020 chronic inflammation Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 235000006694 eating habits Nutrition 0.000 description 3
- 208000030172 endocrine system disease Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 210000003016 hypothalamus Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000003871 intestinal function Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000002427 irreversible effect Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 239000013585 weight reducing agent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- PWDLDBWXTVILPC-WGAVTJJLSA-N CC(C)(N)CC1=CC=CC=C1.C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 Chemical compound CC(C)(N)CC1=CC=CC=C1.C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 PWDLDBWXTVILPC-WGAVTJJLSA-N 0.000 description 2
- 101800001982 Cholecystokinin Proteins 0.000 description 2
- 102100025841 Cholecystokinin Human genes 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920002752 Konjac Polymers 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 102000019280 Pancreatic lipases Human genes 0.000 description 2
- 108050006759 Pancreatic lipases Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 235000004251 balanced diet Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940107137 cholecystokinin Drugs 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 235000020197 coconut milk Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 229960002104 cyanocobalamin Drugs 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 230000004634 feeding behavior Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 230000037219 healthy weight Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000020829 intermittent fasting Nutrition 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000252 konjac Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 229960005060 lorcaserin Drugs 0.000 description 2
- XTTZERNUQAFMOF-QMMMGPOBSA-N lorcaserin Chemical compound C[C@H]1CNCCC2=CC=C(Cl)C=C12 XTTZERNUQAFMOF-QMMMGPOBSA-N 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000018343 nutrient deficiency Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940116369 pancreatic lipase Drugs 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000011755 sodium-L-ascorbate Substances 0.000 description 2
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 235000003563 vegetarian diet Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 102000009394 5-Hydroxytryptamine 2C receptors Human genes 0.000 description 1
- 108050000259 5-Hydroxytryptamine 2C receptors Proteins 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 101710186708 Agglutinin Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100027969 Caenorhabditis elegans old-1 gene Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 206010020740 Hyperproteinaemia Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 235000009815 Momordica Nutrition 0.000 description 1
- 241000218984 Momordica Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 235000004458 antinutrient Nutrition 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000014490 good eating habits Nutrition 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000006362 insulin response pathway Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000005977 kidney dysfunction Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 235000019823 konjac gum Nutrition 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000021486 meal replacement product Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000028280 polygenic inheritance Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 229940103440 qsymia Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- MKWYFZFMAMBPQK-UHFFFAOYSA-J sodium feredetate Chemical compound [Na+].[Fe+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O MKWYFZFMAMBPQK-UHFFFAOYSA-J 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 229940054810 white kidney bean extract Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
- A23L7/107—Addition or treatment with enzymes not combined with fermentation with microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/152—Cereal germ products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a diet composition for weight-losing meal replacement and a preparation method thereof, wherein the diet composition comprises 12-20 parts of cereal powder, 10-16 parts of polydextrose, 7-16 parts of compound grease microcapsules, 2-8 parts of compound traditional Chinese medicine microcapsules, 2-5 parts of traditional Chinese medicine extracts, 5-12 parts of rice protein, 13-22 parts of erythritol, 1-4 parts of pectin, 3-9 parts of Plantago ovata forsk husk powder, 4-10 parts of conjugated linoleic acid glyceride powder, 0.5-1.5 parts of compound minerals, 0.1-0.5 part of compound vitamins, 0.4-1 part of potato extracts and 5-10 parts of plant powder.
Description
Technical Field
The invention relates to the field of foods, in particular to a diet composition for weight-losing meal replacement and a preparation method thereof.
Background
The number of obese people is increasing year by year along with the gradual improvement of people's living standard, the lack of sports, irregular living and eating habits, too much eating of high-calorie, high-fat and high-sugar garbage foods such as fried foods, barbecued foods, cold drinks and the like. The incidence of hyperglycemia, hyperlipidemia and cardiovascular and cerebrovascular diseases caused by obesity is also obviously improved, and the obesity becomes a serious global medical problem and a social problem. In recent thirty years, the prevalence rate of overweight/obesity in China has increased year by year and is in epidemic situation, and the prevalence of overweight and obesity in China between 1992 and 2002 is increased from 14.6% to 21.8% according to the WHO standard. By 2006, obesity has affected the health of more than 2 hundred million Chinese people, by 2016, the overweight and obese population of China is as high as 3.25 hundred million, and the average waist circumference of people increases globally, and the obese people of China is expected to rise rapidly in the coming decades. Obesity is a high risk factor for hyperlipidemia, type ii diabetes, fatty liver, hypertension, cardiovascular disease and cancer, and the number of deaths worldwide is about 300 million each year. The mortality rate caused by chronic diseases such as obesity accounts for 85 percent of the total mortality rate in China, and the disease burden caused by obesity accounts for 70 percent of the total disease burden.
Obesity is not only a physical problem, but more importantly it is extremely health hazardous. Such as cerebrovascular disease, hypertension, arteriosclerosis, coronary heart disease, hyperproteinemia, fatty liver, etc., and obesity is the first disease. A great deal of fat is deposited in blood vessels and organs of a human body, which seriously affects the functional activities of heart and cerebral vessels, a respiratory system, a digestive system and the like, and further causes diseases such as hypertension, myocardial infarction and the like; the abnormal activity of lipid metabolism is the characteristic of obesity patients, excessive free fatty acid generated by metabolism enters the liver and is synthesized into fat to form fatty liver, so that the liver function is abnormal; the prevalence rate of diabetes of obese people is 3 times higher than that of common people, because the obesity can increase the burden of pancreatic islets, and the pancreatic islets are dysfunctional with the passage of time, so that the secreted insulin is relatively insufficient to cause the rise of blood sugar; obesity can reduce immunity due to excessive lipid, and can reduce trace elements such as serum iron and zinc for enhancing immunity, thereby easily causing tumor.
There are three main mechanisms that cause obesity: genetic factors, hyperphagia, mental factors. Obesity belongs to polygenic inheritance, genetic factors are a promoter for inducing obesity, and the formation of obesity is related to the effects of living behaviors, feeding behaviors, hobbies, insulin response and psychosocial factors. After excessive carbohydrate and fat are ingested by a human body, because of lack of exercise and low basal energy metabolic rate, metabolic products of monosaccharide and fatty acid can not be completely used for generating energy, the monosaccharide can be converted into glycogen, the fat is accumulated, and redundant fatty acid can be converted into fat, so that the weight is increased. Bioactive factors in the blood (glucose, free fatty acids, norepinephrine, dopamine, 5-hydroxytryptamine, insulin, etc.) affect the hunger and satiety centers in the hypothalamus, thereby affecting feeding behavior. When the mental is over-stressed and the sympathetic nerve is excited or the adrenergic nerve is stimulated, the appetite is inhibited; appetite is often enhanced when the vagus nerve is excited and insulin secretion is increased.
The traditional obesity treatment adopts drug therapy, and the drug therapy usually has certain side effects, adverse reactions and safety risks, and can cause damage to internal organs of a body; surgical treatment is only for severely obese patients and is expensive, causing irreversible damage to the body; diet and weight loss easily cause nutritional imbalance, gastrointestinal digestive dysfunction, hypoglycemia, endocrine disorder, great injury of primordial qi and other adverse effects, the effect is suitable for the contrary, and the symptoms are treated, the root causes are not treated, and rebound is easy. Exercise therapy can reduce weight, but the effect is not significant, is expensive, takes money, and takes time and energy. The market urgently needs a weight-reducing product which has small side effect, obvious effect, no relapse and treatment of both principal and secondary aspect of disease.
The diet for losing weight is not hungry, but low-calorie balanced diet, and people who want to be flexible, healthy and long-lived can enjoy the pleasure of eating without getting fat only by eating the diet, and should do exercises on and off the low-calorie diet.
The common weight-reducing methods comprise exercise therapy, operation therapy, diet conditioning, drug therapy and the like, wherein the drug therapy mainly refers to taking orlistat which is a pancreatic lipase inhibitor, and further inhibits the decomposition and absorption of fat in food to reduce weight by inhibiting the activity of pancreatic lipase, but fat-soluble vitamin deficiency is caused by the fat diarrhea caused by the drug therapy, and liver function damage can be caused. Central nervous system appetite suppressants 5-hydroxytryptamine 2C receptor agonists lorcaserin (lorcaserin) and Qsymia (a sustained release agent containing phentermine and topiramate) have safety uncertainties in the aspects of the brain center and the cardiovascular system and the like. The chemical medicine has obvious effect, but has certain side effect, adverse reaction and safety risk when being eaten. Most of the drugs such as weight-reducing drugs, weight-reducing tea or oil-expelling pills contain diuretic components, can expel a large amount of water out of the body, and have quick effect but damage to the liver and kidney functions.
The very serious obese people need to rely on surgical operations for cutting the stomach, cutting the intestines and performing liposuction treatment, which is extremely high in cost and can cause irreversible damage to the body. The diet conditioning and weight reducing effect is not obvious, weight reducing refers to balanced diet, blindly diet can only lead to insufficient absorption of nutrient substances needed by the body, lead to nutrition unbalance, gastrointestinal digestive function disorder, hypoglycemia, endocrine disorder and other consequences, the effect can be countervailed, and diet can treat symptoms and root causes but not cause, and is easy to rebound. Exercise therapy can reduce weight, but the effect is not significant, is expensive, takes money, and takes time and energy.
The reasonable exercise is insisted on, the good eating habit is developed in a matching way, and the food and the health food which are combined with the pure natural weight-losing meal replacement are the most reasonable, scientific and healthy weight-losing mode at present. The market urgently needs a weight-losing product and a weight management method which have the advantages of small side effect, obvious effect, no relapse and treatment of both symptoms and root causes.
Aiming at the problem that the incidence of obesity in China is higher and higher, instructional documents such as '2016 edition' and so on commonly known by Chinese overweight/obesity medical nutrition therapists are issued one after another, and scientific diet intervention therapy is proposed. The results of the study show that one of the interventions with the best safety and universality is intermittent fasting (intermittent fasting) mode, also called light fasting "5 + 2" mode, i.e. a normal diet mode with 5 days in 1 week and usual 1/4 energy intake for the other 2 days (non-continuous).
Recent studies have shown that light fasting is not only an easy to adhere method of weight control, but also reduces the risk of many chronic diseases. A study based on 115 obese women published in 2013 showed that after 3 months of intervention, the obese patients with a two-day weaning had an average weight loss of 4 kg, while the obese patients with traditional energy limitation had an average weight loss of 2.4 kg, and the former had a more marked improvement in insulin resistance. In 2014, a Meta analysis about type 2 diabetes prevention shows that light fasting can effectively reduce weight and prevent type 2 diabetes, and metabolic markers such as blood sugar, insulin, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and the like of overweight and obese patients are improved. The 5+2 light fasting regimen regularly affects and acclimates the set point of body fat located in the hypothalamus by temporarily and strictly limiting the energy intake, enhancing the intervention of the usual bad dietary habits; after the body fat content is promoted to deviate from the set point, the hypothalamus promotes the body to return to the original set point by regulating metabolism, namely, mobilizing the fat stored in the body, thereby achieving the purpose of weight management.
Satiety refers to the satisfaction or feeling of fullness and loss of appetite resulting from ingestion of food, which helps manage appetite and hunger, and which helps dieters to prolong satiety, eat less, and control snack-to-meal consumption. Weight management requires increased satiety and decreased food intake.
China is a big obese country, the number of people with gastrointestinal dysfunction, overeating and obesity diseases is increasing rapidly, and people with three highs (hyperglycemia, hypertension and hyperlipidemia) are more and more in China, so that a product which can really realize weight management and weight reduction and has small side effect is urgently needed to be developed.
Therefore, precious resources such as traditional Chinese medicines, medicinal and edible food materials, new food raw materials, natural foods and the like are fully utilized, products with the functions of weight management and weight losing meal replacement are systematically and perfectly researched, popularized and popularized to be enjoyed by the public, the method has a far-reaching practical significance for improving the health level of people in China, and meanwhile, huge social benefits and economic benefits are brought.
CN 105995980A composition with weight management effect and its preparation method disclose that the composition comprising microencapsulated powder, mixed peptide powder, semen Cassiae powder, fructus Siraitiae Grosvenorii powder, semen Scaphii Lychnophori powder, Mori fructus powder, Raphani semen powder, and Mel powder has effects of reducing blood lipid, relaxing bowels, and reducing weight. However, the honey contains high sugar content, the cassia seed and the radish seed can cause severe diarrhea and anthraquinone in the cassia seed and the radish seed can cause the occurrence of the black bowel disease, and the actual effects and side effects of weight management and weight loss are difficult to predict.
CN 108936698A weight management composition and related weight-losing meal replacement products disclose that the weight management composition is composed of soybean protein isolate, concentrated whey protein, dietary fiber, oligosaccharide, sugar alcohol, fish collagen peptide, soybean lecithin, konjac gum and Plantago ovata seed husk, and can strengthen nutrition, enhance satiety, effectively control caloric intake, improve and regulate intestinal flora, improve intestinal function and finally achieve the effect of healthy weight loss. However, the combined formula only contains protein, sugar, dietary fiber and the like, does not contain other nutrient elements such as high-quality fat, vitamins, minerals and the like, is not a full-nutrient composition, causes nutrient deficiency, and has quite limited actual meal replacement effect.
CN 108142789A light-eating nutritional breakfast powder and meal replacement powder set for losing weight and a preparation method thereof disclose a light-eating nutritional breakfast powder for losing weight, which comprises the following raw material components: inulin, soy protein isolate, xylitol, wheat germ powder, rice protein powder, coconut milk powder, kudzu root powder, medium-chain triglyceride powder, yam powder, medlar powder, konjac powder and sucralose; in addition, the application also discloses a light-weight nutritional meal replacement powder set for losing weight, which comprises the light-weight nutritional breakfast powder for losing weight and light-weight nutritional dinner powder for losing weight, and comprises the following raw material components: red date powder, inulin, coconut milk powder, purple rice flour, grain powder, rice protein powder, xylitol, wheat germ powder and sucralose. The combined formula of the nutritional food only contains high-quality fat, protein, sugar, dietary fiber and the like, does not contain vitamins, minerals and other nutritional elements, is not a full nutritional composition, can cause nutrient deficiency, and has quite limited actual meal replacement effect.
Disclosure of Invention
The invention aims to provide a diet composition for weight-losing meal replacement and a preparation method thereof, wherein the diet composition for weight-losing meal replacement is complete in nutrition, low in calorie, high in protein content and high in fiber content, is particularly suitable for weight-losing people needing customized nutrition energy supply ratio, and is safe in quality and completely depends on natural properties and flavor collocation of raw materials because no preservative, artificial pigment, essence and spice are added.
Another object of the present invention is to provide a diet composition for a diet substitute, wherein a user can achieve the actual effects of reducing weight and improving body weight without damaging viscera after eating the diet composition for a diet substitute.
Another object of the present invention is to provide a diet composition for meal replacement for weight loss, wherein the diet composition for meal replacement for weight loss ensures accurate and quantitative nutrient intake, and has the effects of mild conditioning, relaxing bowel, expelling toxin and reducing fat, regulating intestinal microecological balance, regulating blood lipid balance and reducing the content of cholesterol and triglyceride in blood, thereby practically realizing the efficacy requirements of weight management and meal replacement for weight loss, and minimizing or avoiding adverse reactions and side effects.
To achieve at least one of the above objects of the present invention, the present invention provides a diet composition for a diet replacement, comprising:
12-20 parts of cereal powder
10-16 parts of polydextrose
7-16 parts of composite oil microcapsule
2-8 parts of composite traditional Chinese medicine microcapsules
2-5 parts of traditional Chinese medicine extract
5-12 parts of rice protein
13-22 parts of erythritol
1-4 parts of pectin
3-9 parts of plantain seed shell powder
4-10 parts of conjugated linoleic acid glyceride powder
0.5-1.5 parts of composite mineral
0.1-0.5 part of compound vitamin
0.4-1 part of potato extract
5-10 parts of plant powder.
According to an embodiment of the invention, the grain powder is plant nutrition powder integrated by germination, microwave drying, low-temperature superfine grinding, enzymolysis emulsification and spray drying, wherein the mass ratio of millet, sorghum, mung bean, barley, coix seed and hulless oat is 1-2: 1-3: 3-5: 1-2: 2-4, and the content of gamma-aminobutyric acid is 480-1380 mg/kg.
According to an embodiment of the invention, the composite oil microcapsule is prepared by taking poppy seed oil, antarctic krill oil, red date polysaccharide, tremella polysaccharide, rosemary extract, gamma-cyclodextrin, sucrose fatty acid ester, sodium alginate and pectin as raw materials and carrying out microcapsule double-layer embedding and spray drying, wherein the mass ratio of the poppy seed oil to the antarctic krill oil is 3-4: 1-3, the embedding rate of the composite oil microcapsule is up to more than 95%, and the particle size of the composite oil microcapsule is 230-380 μm.
According to an embodiment of the invention, the traditional Chinese medicine extract adopts the raw materials of tartary buckwheat and sophora flower in a mass ratio of 2-3.5: 1-2.5; the conjugated linoleic acid glyceride powder is prepared from the following raw materials in parts by mass, namely, the conjugated linoleic acid glyceride, glucose syrup, sodium caseinate, potassium dihydrogen phosphate and silicon dioxide, wherein the mass ratio of the conjugated linoleic acid glyceride powder to the glucose syrup to the sodium caseinate to the potassium dihydrogen phosphate to the silicon dioxide is 11-13: 1-3: 2-4: 1-3: 0.5 to 1.5; the composite mineral substance is prepared from calcium hydrophosphate, magnesium carbonate, sodium iron ethylene diamine tetraacetate, zinc gluconate and maltodextrin, wherein the mass ratio of the calcium hydrophosphate to the magnesium carbonate to the sodium iron ethylenediamine tetraacetate to the zinc gluconate to the maltodextrin is 1-3: 3-5: 4-6: 2-3: 9-11; wherein the compound vitamin adopts raw materials of L-sodium ascorbate, nicotinic acid, vitamin A acetate, D-calcium pantothenate, thiamine hydrochloride, pyridoxine hydrochloride, riboflavin, and vitamin D3Folic acid, cyanocobalamine and maltodextrin, wherein the mass ratio of folic acid to cyanocobalamine to maltodextrin is 42-46: 3-4: 2.5-3.5: 1.5-2.5: 0.4-0.6: 0.5-0.7: 0.4-0.5: 0.003-0.006: 0.06-0.09: 0.0005 to 0.0015: 90-110; wherein the plant powder adopts balsam pear extract and rhizoma alismatis extract which are raw materials, and the mass ratio of the balsam pear extract to the rhizoma alismatis extract is 1-2: 3 to 5.
According to another aspect of the present invention, the present invention provides a method for preparing a diet composition for a diet substitute, wherein the method for preparing the diet composition for a diet substitute comprises:
(S1) processing semen setariae, jowar, semen phaseoli radiati, fructus Hordei vulgaris, semen Coicis, and herba Avenae Fatuae by germination, microwave drying, low-temperature micronization, enzymolysis, emulsification, and spray drying to obtain cereal powder;
(S2) preparing compound oil microcapsules by using poppy seed oil, antarctic krill oil, red date polysaccharide, tremella polysaccharide, rosemary extract, gamma-cyclodextrin, sucrose fatty acid ester, sodium alginate and pectin as raw materials through microcapsule double-layer embedding, spray drying and other process technologies;
(S3) processing cortex Cinnamomi, fructus Juniperi, α -cyclodextrin, sodium alginate, and silicon dioxide by supercritical CO2Extracting and microcapsule embedding to obtain composite Chinese medicinal microcapsule;
(S4) processing radix Et rhizoma Fagopyri Tatarici and flos Sophorae Immaturus into coarse powder, extracting with ultrasonic ethanol, concentrating, refining with column, and spray drying to obtain Chinese medicinal extract;
(S5) boiling and granulating conjugated linoleic acid glyceride, glucose syrup, sodium caseinate, potassium dihydrogen phosphate and silicon dioxide, crushing and sieving to prepare conjugated linoleic acid glyceride powder;
(S6) sieving calcium hydrogen phosphate, magnesium carbonate, sodium iron ethylene diamine tetraacetate, zinc gluconate and maltodextrin, and three-dimensionally mixing to obtain compound mineral;
(S7) adopting L-sodium ascorbate, nicotinic acid, vitamin A acetate, D-calcium pantothenate, thiamine hydrochloride, pyridoxine hydrochloride, riboflavin, and vitamin D3Sieving folic acid, cyanocobalamine and maltodextrin as raw materials, triple premixing and three-dimensional mixing to prepare the compound vitamin;
(S8) preparing potato extract from potato by crushing and size mixing, ultrasonic-assisted enzymolysis, centrifugal filtration, ion exchange, membrane filtration, vacuum freeze drying and other processes;
(S9) preparing plant powder by sieving the bitter gourd extract and the alisma orientale extract and performing three-dimensional mixing process operation;
(S10) uniformly mixing the prepared cereal powder, composite oil microcapsules, composite traditional Chinese medicine microcapsules, traditional Chinese medicine extracts, conjugated linoleic acid glyceride powder, composite mineral substances, composite vitamins, potato extracts, plant powder and other raw materials such as polydextrose, rice protein, erythritol, pectin, psyllium husk powder and the like for 15-25 min by using a three-dimensional mixer, wherein the operation frequency is 18-30 Hz, and taking out the mixture to obtain the required diet-stopping composition.
According to an embodiment of the present invention, the method for preparing the diet composition for meal replacement for weight loss comprises preparing a cereal flour, wherein the preparing of the cereal flour comprises the following steps:
(Y1) germination of the grain: weighing barley and hulless oat, soaking the barley and the hulless oat in purified water for 18-24 hours, taking out the barley and the hulless oat, draining the water, placing the barley and the hulless oat in a constant-temperature constant-humidity germination room for germination, wherein the temperature is constant at 21 +/-1 ℃, the relative humidity is constant at 85 +/-2%, the germination time is 72-96 hours, removing roots, and cleaning for later use;
(Y2) microwave drying: performing microwave drying on the barley germs and the hulless oat germs obtained in the step (Y1), wherein the microwave power is 20-40 Kw, the drying temperature is kept at 70-80 ℃, and the drying time is 120-150 min;
(Y3) carrying out low-temperature ultrafine grinding: uniformly mixing millet, sorghum, mung bean, barley germ, coix seed and hulless oat germ, putting into a low-temperature superfine grinding device for superfine grinding, and sieving with a 500-mesh sieve to obtain grain superfine powder;
(Y4) carrying out enzymolysis and emulsification, namely putting the ultrafine grain powder into purified water of which the temperature is 12-16 times, uniformly stirring to prepare a dispersion, heating to raise the temperature and keep the temperature at 50 +/-2 ℃, adding β -amylase into the dispersion, uniformly stirring and carrying out enzymolysis for 1.5-2.5 hours, wherein β -amylase is added in an amount of 0.4-0.8% of the content of the substrate, adjusting the pH to 2.5-4.5, adding pectinase into the dispersion, uniformly stirring and carrying out enzymolysis for 2.0-2.5 hours at 50 +/-3 ℃, wherein the addition of the pectinase is 0.25-0.4% of the content of the substrate, adjusting the pH to 7.5-8.5, adding trypsin into the dispersion, uniformly stirring and carrying out enzymolysis for 1.5-2.5 hours at 37 +/-1 ℃, wherein the addition of the trypsin is 0.35-0.65% of the content of the substrate, and carrying out enzyme deactivation by using a high-temperature instant enzyme deactivation method after the enzymolysis is finished;
(Y5) concentration under reduced pressure: concentrating the clear liquid under reduced pressure, controlling the concentration temperature to be 70-75 ℃, controlling the vacuum degree to be-0.08-0.095 Mpa, and controlling the relative density to be 1.05-1.08 to obtain an extract;
(Y6) spray drying: and sterilizing and filtering the extract, and then spray-drying, wherein the process parameters are that the nozzle temperature is 175-182 ℃, the outlet temperature is 85-90 ℃, and the feeding speed is 2.5-3.0L/min, so as to obtain the cereal powder.
According to an embodiment of the invention, the preparation method of the diet composition for weight loss meal replacement comprises the following steps of preparing the compound oil microcapsules:
(Z1) preparing a first wall material/core material solution, namely uniformly stirring poppy seed oil and antarctic krill oil in the mass ratio to prepare a mixed oil core material solution, uniformly mixing red date polysaccharide, rosemary extract, gamma-cyclodextrin and sucrose fatty acid ester, adding a proper amount of water, and fully stirring and dissolving to prepare a wall material solution with the mass fraction (m/m) of 25-30%, wherein the mass ratio of the red date polysaccharide to the rosemary extract to the gamma-cyclodextrin to the sucrose fatty acid ester is 7-9: 0.4-0.6: 9-11: 0.5 to 1.5;
(Z2) embedding a layer, namely, mixing the grease core material solution and the wall material solution in the step (Z1) according to the ratio of 2-3: 3-5, emulsifying and homogenizing for 8-12 min at the rotating speed of 2500-3500 r/min by using an emulsifying homogenizer, standing for 3h, separating a water outlet layer by using an oil-water separator, discarding, and collecting an oil layer for later use;
(Z3) preparing a second wall material/core material solution, namely taking the oil layer in the step (Z2) as the second core material solution, uniformly mixing tremella polysaccharide, sodium alginate, gamma-cyclodextrin and pectin, adding a proper amount of water, fully stirring and dissolving to prepare a wall material solution with the mass fraction (m/m) of 30-35%, wherein the mass ratio of the tremella polysaccharide to the sodium alginate to the gamma-cyclodextrin to the pectin is 10-12: 0.5-1.5: 9-13: 1-3;
(Z4) two-layer embedding, i.e. mixing the second core material solution and the wall material solution in the step (Z3) according to the ratio of 1.5: mixing the raw materials according to the mass ratio of 1-2.5, and continuously stirring for 10-15 min to prepare a secondary embedding solution;
(Z5) spray drying, namely, spray drying the secondary embedding liquid in the step (Z4) to obtain the compound oil microcapsule, wherein the process parameters are that the nozzle temperature is 180-185 ℃, the outlet temperature is 85-95 ℃, and the feeding speed is 2.5-3.0L/min, and the red date polysaccharide (tremella polysaccharide) in the steps (Z1) and (Z3) can be prepared through the following steps:
(Z6) enzymolysis: taking crushed red date ultrafine powder (tremella ultrafine powder), adding water which is 15-45 times of the weight of the materials and 1.0-2.5% of pectinase, performing enzymolysis for 50-90 min at a constant temperature of 45-55 ℃, and heating to above 95 ℃ to inactivate the enzyme;
(Z7) extraction: carrying out heat preservation extraction at the temperature of 95-100 ℃, filtering by using a 500-mesh screen to obtain a red date polysaccharide (tremella polysaccharide) extracting solution, wherein the extracting times are 1-2 times, and the extracting time is 1-3 hours each time;
(Z8) ion exchange: performing impurity removal and decoloration treatment on the filtered red date polysaccharide (tremella polysaccharide) extract through an ion exchange column and an active carbon column;
(Z9) concentration in vacuo: carrying out vacuum concentration on the solution after ion exchange, wherein the concentration temperature is 65-85 ℃, and the vacuum degree is-0.075-0.095 Mpa, so as to obtain a red date polysaccharide concentrated solution (tremella polysaccharide concentrated solution), and the relative density is controlled to be 1.03-1.05;
(Z10) vacuum freeze drying: the red date polysaccharide concentrated solution (tremella polysaccharide concentrated solution) is prepared into red date polysaccharide powder (tremella polysaccharide powder) through a vacuum freeze drying technology, wherein the pre-freezing initial temperature is-38 ℃ to-48 ℃, the pre-freezing speed is 0.3-0.6 ℃/min, the pre-freezing final temperature is-75 ℃, the pressure of a drying chamber is 45-110 pa, the temperature of a heating plate is 35-45 ℃, and the drying time is 20-26 h.
According to an embodiment of the invention, the preparation method of the diet composition for weight loss meal replacement comprises the following steps of preparing a composite traditional Chinese medicine microcapsule, wherein the preparation method of the composite traditional Chinese medicine microcapsule comprises the following steps:
supercritical CO2And (3) extraction: sieving coarse powder of cinnamon and juniper berries by a 6-8-mesh sieve, and then sieving the coarse powder with CO2Extracting by supercritical extraction (extraction temperature is 35-42 ℃, extraction pressure is 32-38 Mpa, CO is2The flow rate is 9-15 kg/h, the extraction time is 120-150 min, the separation pressure is 4-5MPa, the separation temperature is 35-40 ℃), and oily extracts of cinnamon and juniper berries are obtained through separation;
(II) carrying out microcapsule embedding integrated forming, namely weighing an appropriate amount of α -cyclodextrin, sodium alginate and silicon dioxide before the beginning of the step (I), uniformly mixing, placing the mixture at the bottom layer of a separation kettle of a supercritical extraction device for microcapsule embedding integrated forming, wherein the mass ratio of α -cyclodextrin, sodium alginate and silicon dioxide is 7-9: 1-2: 0.2-1.0, the total amount of mixed powder of the three is 5-10% of the total amount of coarse powder of cinnamon and juniper seeds, extracting grease of the cinnamon and the juniper seeds enters a preheater for heating through the top of the extraction kettle, reducing the pressure to 4-5MPa in the separation kettle, and CO is introduced into the separation kettle2After separation, the CO enters from the top side part of the separation kettle2Recovering and circulating the total storage tank, forming sinking cyclone by oily cortex Cinnamomi and fructus Juniperi extract in a separation kettle through vortex flow guide gas port, mixing with α -cyclodextrin, sodium alginate and silicon dioxide powder under the action of high pressure gas flow, embedding in the separation kettle to obtain composite Chinese medicinal microcapsule powder, molding in one step to avoid the problem of low stability of the extractLoss and loss of functional components of the embedding material by the spray drying process, process compression, cost saving, and inert gas CO in the separation embedding kettle2Protecting, performing cyclone embedding at low temperature, and avoiding oxidative decomposition of effective components, wherein the composite Chinese medicinal microcapsule is prepared from cortex Cinnamomi and fructus Juniperi as raw materials by supercritical CO2The extract is prepared by extraction and microcapsule embedding integrated forming technology, wherein the embedding rate of functional components in the composite traditional Chinese medicine microcapsule is more than 90%, and the particle size is 100-230 microns, compared with the traditional alcohol extraction method, the cinnamon and juniper berry extract prepared by the method has the advantages that the process operation of one-step forming abandons the traditional alcohol extraction process which needs concentration and spray drying, the extraction time is greatly shortened by more than 50%, and the extraction yield is improved by more than 30%.
According to an embodiment of the invention, the preparation method of the diet composition for weight loss meal replacement comprises the following steps of preparing a vitamin complex, wherein the preparation method of the vitamin complex comprises the following steps:
(H1) sieving, namely weighing the L-sodium ascorbate and the maltodextrin in the mass fraction for later use; weighing the nicotinic acid, the vitamin A acetate, the D-calcium pantothenate, the thiamine hydrochloride, the pyridoxine hydrochloride, the riboflavin and the vitamin D according to the mass fraction3Uniformly sieving folic acid and cyanocobalamine with a disk vibrating sieve to obtain vitamin sieving powder, wherein the mesh number of the sieve is 80-100 meshes;
(H2) triple premixing, namely putting the vitamin sieving powder obtained in the step (H1) and maltodextrin with the same weight as the vitamin sieving powder into a small three-dimensional mixer for three-dimensional premixing, wherein the mixing time is 10-15 min, and the mixing frequency is 15-20 Hz; repeating the above operations twice according to an equivalent incremental method, adding maltodextrin with the same weight as the mixed powder each time for premixing, and repeating the above operations twice;
(H3) and (3) three-dimensional mixing, namely uniformly placing the triple premixed powder obtained in the step (H2), the L-sodium ascorbate and the rest maltodextrin in a three-dimensional mixer for three-dimensional mixing, wherein the mixing time is 20-35 min, and the mixing frequency is 18-25 Hz, so that the multivitamin is prepared for later use, the mixing uniformity of the effective components of the multivitamin is particularly high due to the adoption of the preparation processes of sieving, triple premixing and three-dimensional mixing, and the RSD values of the effective components obtained by sampling and measuring at different sampling points are all less than 0.6%.
According to an embodiment of the present invention, the method for preparing the diet composition for slimming meal replacement comprises preparing a potato extract, wherein the method for preparing the potato extract comprises:
(K1) crushing and mixing the pulp, namely cleaning and peeling fresh potatoes, adding purified water with the weight 30-40 times that of the materials, fully stirring and crushing the materials into potato pulp, and adjusting the pH value to 4.0;
(K2) performing ultrasonic-assisted enzymolysis, namely adding pectinase accounting for 0.5-2% of the weight of the potato pulp and α -amylase accounting for 1-1.5% of the weight of the potato pulp into the potato pulp prepared in the step (K1), performing enzymolysis at a constant temperature of 45-50 ℃ for 60-90min, and improving enzymolysis efficiency by ultrasonic-assisted enzymolysis with the ultrasonic power of 100-200W;
(K3) performing centrifugal filtration, namely performing centrifugal impurity removal on the enzymolysis liquid prepared in the step (K2), keeping the centrifugal rotation speed of 13000-17000 r/min and the feeding speed of a peristaltic pump of 2.2-3.3L/min, and collecting supernatant;
(K4) ion exchange, namely, the enzymolysis supernatant fluid prepared in the step (K3) passes through an ion exchange column and an activated carbon column to be subjected to impurity removal, decoloration and deodorization treatment;
(K5) membrane filtration, namely starting membrane filtration equipment, filtering supernate by using a microporous filter membrane, wherein the thickness of the filter membrane is 120-160 mu m, the filtered particle size is 8-20 mu m, the operating pressure is 0.05-0.45 MPa, and collecting protein filter residues;
(K6) and (4) performing vacuum freeze drying, namely preparing the protein filter residue prepared in the step (K5) into a potato extract by using a vacuum freeze drying technology, wherein the pre-freezing initial temperature is-40 to-45 ℃, the pre-freezing speed is 0.3 to 0.4 ℃/min, the pre-freezing final temperature is-75 ℃, the pressure in a drying chamber is 7 to 110pa, the temperature of a heating plate is 35 to 45 ℃, and the drying time is 20 to 24 hours.
The formula and the design of the technical scheme completely follow the health concept of nutrition weight loss and vegetarian diet health preservation in modern medicine, and are derived from a nutrition weight loss method mode with unique health preserving genes. The composition disclosed by the invention is full in nutrition, low in calorie, high in protein and high in fiber, the nutrition energy supply ratio is specially customized for weight-losing people, preservatives, artificial pigments, essences and spices are not added, the quality is safe, and the target sensory properties of the product are matched completely depending on the natural properties and the flavor of raw materials. The invention fully grasps the dose-effect relationship among the raw materials, and the combination of the raw materials can realize synergistic effect and fully exert the effects of weight management and weight loss meal replacement.
The diet composition has the following design and efficacy principles:
the functional factors are definite in orientation, full-nutrient, low in calorie, high in protein and high in fiber, are specially created for nutritional energy supply and meal replacement of weight-losing people, low in GI (GI value less than 55) for slowly increasing sugar, improving basic metabolism level, reducing accumulation of chronic inflammation, assisting in burning fat, inhibiting hunger sensation, providing high satiety, strengthening and intervening in poor dietary habits formed at ordinary times, reducing appetite threshold, rich in compound dietary fiber and prebiotics, and capable of more effectively improving gastrointestinal tract functions, mildly conditioning, expelling toxin and reducing fat.
The design concept of the delicacy composition is as follows:
the weight-losing weight-reducing meal replacement preparation has the advantages that the actual effects of losing weight and improving weight are achieved, organs are not damaged, the nutrient intake is accurately quantified, the effects of mildly conditioning, relaxing bowel, expelling toxin and reducing fat, regulating intestinal microecological balance, regulating blood fat balance and reducing the contents of cholesterol and triglyceride in blood are achieved, so that the weight management and weight-losing meal replacement effects are practically realized, and adverse reactions and side effects are reduced or avoided to the greatest extent.
In the process of developing the diet composition, traditional Chinese medicine and food raw materials with extremely small toxic and side effects are strictly screened, and high-quality grease (composite grease microcapsules and conjugated linoleic acid glyceride powder), high-quality carbohydrate (grain powder and erythritol) and high-quality protein (rice protein and grain powder) are used for meal replacement; the cinnamon and the juniper berries are prepared into composite traditional Chinese medicine micro-capsules, the tartary buckwheat and the sophora flower are prepared into traditional Chinese medicine extracts, the potatoes extract an effective component protease inhibitor (PI 2), and plant powder prepared from the balsam pear extract and the rhizoma alismatis extract is used as four effective components to enhance the effects of weight management and weight reduction of the delicacy composition;
the cereal powder, the compound mineral substance and the compound vitamin are used as the sources of the vitamin and the mineral substance to meet the requirement of the vitamin and the mineral substance every day; the dietary fiber (Plantago ovata forsk husk powder, polydextrose and pectin) and the prebiotics (polydextrose) are used for regulating the health of intestinal tracts, promoting the proliferation of probiotics, improving the micro-ecological environment of the intestinal tracts, and meanwhile, the high-content dietary fiber can absorb a large amount of water and swell to generate strong satiety, reduce the food intake desire, wrap fat particles, reduce fat absorption, promote the gastrointestinal tract peristalsis and promote the intestinal emptying.
The composition can be prepared by processing and extracting the medicines and food raw materials through various technical means, can be prepared into various dosage forms such as tablets, hard capsules, granules, solid beverages and the like by adding other raw and auxiliary materials, can be used in combination with protein rods and light-eating compositions in a weight-reducing set meal, and has the advantages of reducing the dosage, improving the bioavailability and user experience and prolonging the shelf life of the product.
Compared with the prior art, the technical scheme adopted by the invention has the following advantages:
(1) the bottleneck of the prior art is broken through, and a brand new preparation process with optimized design is innovatively improved through a large amount of orthogonal experimental designs and single-factor experimental investigation.
The grain powder is prepared into the plant nutrition powder by adopting the technologies of grain germination, microwave drying, low-temperature superfine grinding, enzymolysis emulsification, spray drying and the like in an integrated and innovative way, wherein the content of gamma-aminobutyric acid is up to 480-1380 mg/kg.
The composite oil microcapsule is formed by double-layer embedding and spray drying of the microcapsule, the quality guarantee period and stability of oil are greatly prolonged, the quality of products is greatly improved, the embedding rate of the microcapsule is up to more than 95%, and the particle size is 230-380 microns. The obtained composite oil microcapsule has good emulsifying property and good stability to light and heat.
The composite Chinese medicinal microcapsule adopts supercritical CO2The extraction and the microcapsule embedding are processed by an integral forming technology, so that a great deal of time, energy and cost are saved, and inert gas CO is contained in a separation embedding kettle2Protection, cyclone embedding in low temperature environment, no temperature rise process, and avoidance of oxidative decomposition of effective components. The embedding rate of the functional components in the composite traditional Chinese medicine microcapsule is more than 90%, and the particle size is 100-230 mu m. The obtained composite traditional Chinese medicine microcapsule has good solubility and good stability to light and heat. CO 22Compared with the traditional alcohol extraction method, the cinnamon and juniper berry extracts prepared by the method have the advantages that the one-step forming process operation abandons the traditional alcohol extraction process which needs concentration and spray drying, the extraction time is greatly shortened by over 50 percent, and the extraction yield is improved by over 30 percent.
The traditional Chinese medicine extract is prepared by the technologies of ultrasonic alcohol extraction, concentration, column-passing refining, spray drying and the like, perfectly maintains the functional components of the tartary buckwheat and the sophora flower, such as flavone and the like, reduces the edible amount, improves the bioavailability, and improves the content of the total flavone by more than 50 percent compared with the traditional alcohol extraction method.
The conjugated linoleic acid glyceride powder is prepared by boiling granulation, crushing and sieving, and the conjugated linoleic acid glyceride is prepared into powder after the boiling granulation, so that the application convenience is greatly improved, and the fluidity is also greatly improved.
The composite vitamin is prepared by unique mixing processing technologies such as sieving, triple premixing, three-dimensional mixing and the like, the mixing uniformity of the effective components is extremely high, and the RSD values of the effective components are less than 0.6% through sampling and measuring at different sampling points.
The potato extract is prepared by processes of size mixing, ultrasonic-assisted enzymolysis, centrifugal filtration, ion exchange, membrane filtration, vacuum freeze drying and the like, so that a protease inhibitor in the extract is greatly protected from being damaged by extraction conditions such as temperature and the like, the purity of the inhibitor is greatly improved, the actual application effect is greatly improved, and the content of the protease inhibitor (PI 2) in the obtained extract is more than 58.6 g/kg.
The advanced technologies are creatively combined together, corresponding operation steps and process parameters are groped out, and the method is applied to the preparation method of the diet composition with the weight management and weight-losing meal replacement functions, so that the efficacy and the bioavailability are greatly improved, and the eating amount is reduced.
(2) The invention completely follows the health concept of modern medical nutrition weight loss and vegetarian diet health preservation, and is derived from a nutrition weight loss method mode with unique health preserving genes, namely a 'vegetarian' nutrition weight loss '5 + 2' light delicacy mode. The composition disclosed by the invention is full in nutrition, low in calorie, high in protein and high in fiber, the nutrition energy supply ratio is specially customized for weight-losing people, preservatives, artificial pigments, essences and spices are not added, the quality is safe, and the target sensory properties of the product are matched completely depending on the natural properties and the flavor of raw materials. The functional factors are definite in orientation, the basal metabolic level is improved, the accumulation of chronic inflammation is reduced, fat is combusted in an auxiliary mode, hunger sensation is inhibited, high satiety is provided, the composite dietary fiber and prebiotics are enriched, and intestinal tract regulation can be performed more effectively. The design concept is as follows: high-quality fat, carbohydrate and protein are used for meal replacement, so that the nutrient intake can be accurately quantified, and excessive intake is avoided. The weight management and weight losing effects of the diet composition are enhanced by using the effective components of the compound traditional Chinese medicine microcapsules, the traditional Chinese medicine extract, the potato extract and the plant powder. The cereal powder, the compound mineral substances and the compound vitamins are used as the sources of the vitamins and the mineral substances to meet the daily requirement of the vitamins and the mineral substances. The dietary fiber and prebiotics are used to regulate intestinal health, promote proliferation of probiotics, improve intestinal micro-ecological environment, reduce fat absorption, and promote intestinal emptying. The diet composition strictly screens traditional Chinese medicine and food raw materials with extremely small toxic and side effects, achieves the effect of improving the intestinal function without damaging viscera, mildly conditions and expels toxin, reduces blood fat and reduces weight, thereby practically realizing the function requirements of weight management and weight reduction meal replacement. The invention fully grasps the dose-effect relationship among the raw materials, and the combination of the raw materials can realize synergistic effect and fully exert the effects of weight management and weight loss meal replacement.
(3) In the traditional obesity drug treatment, certain side effects, adverse reactions and safety risks exist when the traditional obesity drug is eaten, and the damage to internal organs of a body can be caused; surgical treatment is only for severely obese patients and is expensive, causing irreversible damage to the body; diet and weight loss easily cause the consequences of nutrient unbalance, gastrointestinal digestive function disorder, hypoglycemia, endocrine disorder and the like, the effect is suitable for the contrary, the symptoms are treated, the root causes are not treated, and rebound is easy. Exercise therapy can reduce weight, but the effect is not significant, is expensive, takes money, and takes time and energy. The invention relates to a medicine composition, which is prepared by screening traditional Chinese medicine raw materials with extremely small toxic and side effects, matching natural and healthy new food raw materials and food raw materials, and intensively researching to determine the traditional Chinese medicine proportion and the dose-effect relationship thereof, elaborately composing the formula, guaranteeing the edible safety, having no toxic and side effects, achieving the effect of improving the gastrointestinal tract function, having no damage to viscera, mildly conditioning, expelling toxin and reducing fat, and treating both principal and secondary aspects of diseases, thereby practically realizing the function requirements of weight management and weight-reducing meal replacement.
(4) The diet composition with the weight management and weight-losing meal replacement functions has the advantages of strong universal applicability of the preparation method, suitability for production and processing of various dosage forms such as tablets, hard capsules, granules, solid beverages and the like, easy operation, stable process, controllable quality, high production efficiency and high economic added value, and is suitable for large-scale and industrial production.
Detailed Description
The preferred embodiments in the following description are given by way of example only, and other obvious variations will occur to those skilled in the art. The basic principles of the invention, as defined in the following description, may be applied to other embodiments, variations, modifications, equivalents, and other technical solutions without departing from the spirit and scope of the invention.
The diet composition for the diet substitute according to a preferred embodiment of the present invention will be described in detail below, wherein the diet composition for the diet substitute has complete nutrition, low calorie, high protein content and high fiber content, and is particularly suitable for the diet people who need to customize nutrition energy supply ratio.
The diet composition for weight loss meal replacement comprises the following components:
12-20 parts of cereal powder
10-16 parts of polydextrose
7-16 parts of composite oil microcapsule
2-8 parts of composite traditional Chinese medicine microcapsules
2-5 parts of traditional Chinese medicine extract
5-12 parts of rice protein
13-22 parts of erythritol
1-4 parts of pectin
3-9 parts of plantain seed shell powder
4-10 parts of conjugated linoleic acid glyceride powder
0.5-1.5 parts of composite mineral
0.1-0.5 part of compound vitamin
0.4-1 part of potato extract
5-10 parts of plant powder.
The grain powder in the formula adopts millet, sorghum, mung bean, barley, coix seed and hulless oat as raw materials, and adopts plant nutrition powder which is integrated and innovated by the technologies of grain germination, microwave drying, low-temperature ultra-micro crushing, enzymolysis emulsification, spray drying and the like. Preferably, the mass ratio of the millet to the sorghum to the mung bean to the barley to the coix seed to the hulless oat is 1-2: 1-3: 3-5: 1-2: 2-4, and the content of the gamma-aminobutyric acid is up to 480-1380 mg/kg.
It is worth mentioning that the grain powder coagulates natural nutrients in grains, is rich in protein, amino acid and dietary fiber, has more comprehensive and reasonable amino acid combination, reasonable proportion of omega-3 fatty acid and omega-6 fatty acid, and is natural, nutritional, healthy and safe. After the hulless oat and the barley are subjected to germination treatment, the content of an allergen is reduced, the content of anti-nutrients such as phytic acid, polyphenol and agglutinin is reduced, the content of amino acid and dietary fiber is increased, the absorption and utilization rate of protein, vitamin and mineral substances is increased, and grains are easier to digest and absorb. The hulless oat powder has high protein content and complete amino acid types, and 8 kinds of amino acids necessary for human bodies have high and balanced content. The lysine content of naked oats is more than 2 times of that of rice, wheat flour, corn flour, sorghum rice and millet, and is about 1.8 times of that of large yellow rice. The content of methionine, threonine, phenylalanine, valine, isoleucine and tryptophan of naked oats is much higher than that of other cereal grains.
It is worth mentioning that polydextrose is a water-soluble dietary fiber, and has the effects of regulating lipid metabolism, reducing cholesterol, regulating the balance of intestinal flora, reducing sugar absorption, preventing and treating constipation, removing toxic substances and caring skin.
The composite oil microcapsule in the formula is prepared by adopting poppy seed oil, antarctic krill oil, red date polysaccharide, tremella polysaccharide, rosemary extract, gamma-cyclodextrin, sucrose fatty acid ester, sodium alginate and pectin as raw materials through microcapsule double-layer embedding and spray drying, so that the quality guarantee period and stability of the oil are greatly prolonged, and the quality of the product is greatly improved. Preferably, the mass ratio of the poppy seed oil to the antarctic krill oil is 3-4: 1-3, the embedding rate of the composite oil microcapsule is up to more than 95%, and the particle size is 230-380 μm. The obtained composite oil microcapsule has good emulsifying property and good stability to light and heat.
It is worth mentioning that poppy seed oil in the composite oil microcapsule is rich in alkaloid, polyunsaturated fatty acid, vitamin E, polysaccharide, polypeptide, alcohol, flavone and other more than 100 natural active substances, the most precious is that it contains more than 10 unsaturated fatty acids which are necessary for human body but can not be synthesized by the human body, the biological absorptivity is high, the effects are mutually cooperated, and the superposition is multiplied, so that the poppy seed oil microcapsule is miraculous in nutritive value. The Antarctic krill oil is mainly extracted from Antarctic sea area, is a small red krill, contains Omega-3 essential fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and can prevent and improve cardiovascular and cerebrovascular diseases, help to reduce cholesterol, promote blood circulation, delay aging, and improve immunity.
The composite traditional Chinese medicine microcapsule in the formula adopts cinnamon and juniper berries as raw materials and is processed by supercritical CO2The extract and the microcapsule embedding are processed by an integral forming technology. Preferably, the mass ratio of cinnamon to juniper berries is 0.2-0.8: 3 to 5. Preferably, the composite traditional Chinese medicine microcapsule is prepared by subjecting cinnamon and juniper berries to supercritical CO2The extraction and the microcapsule embedding are integrally formed, so that a great deal of time, energy and cost are saved, and inert gas CO is contained in the separation embedding kettle2Protection, cyclone embedding in low temperature environment, no temperature rise process, and avoidance of oxidative decomposition of effective components. The embedding rate of the functional components in the composite traditional Chinese medicine microcapsule is more than 90%, and the particle size is 100-230 mu m. The obtained composite traditional Chinese medicine microcapsule has good solubility and good stability to light and heat. CO 22Compared with the traditional alcohol extraction method, the cinnamon and juniper berry extracts prepared by the method have the advantages that the one-step forming process operation abandons the traditional alcohol extraction process which needs concentration and spray drying, the extraction time is greatly shortened by over 50 percent, and the extraction yield is improved by over 30 percent.
It is worth mentioning that the cinnamon in the composite traditional Chinese medicine microcapsule is dry bark of cinnamon of Lauraceae, is pungent and sweet in taste, has great heat, enters kidney, spleen, heart and liver channels, has the functions of tonifying fire and supporting yang, returning to original qi due to fire, dispelling cold and relieving pain and warming and dredging channels and collaterals, and most importantly has the unique effects of reducing blood sugar and regulating lipid and is unknown. The juniper berries are berries of juniper berries, and the essential oil of juniper berries has strong antibacterial property, is helpful for expelling toxin and promoting urination and eliminating chronic diseases, and most importantly, has unique effects of reducing blood sugar and regulating lipid.
The traditional Chinese medicine extract in the formula is prepared by taking tartary buckwheat and sophora japonica as raw materials and carrying out coarse powder, ultrasonic alcohol extraction, concentration, column chromatography refining and spray drying, so that functional ingredients such as flavone in tartary buckwheat and sophora japonica are perfectly maintained, the edible amount is reduced, and the bioavailability is improved. Preferably, the mass ratio of the tartary buckwheat to the sophora flower is 2-3.5: 1-2.5, and the content of total flavonoids is improved by more than 50% compared with that of the traditional alcohol extraction method.
It is worth mentioning that the tartary buckwheat in the traditional Chinese medicine extract is bitter and neutral in taste, has the effects of regulating qi, relieving pain, tonifying spleen, promoting diuresis, benefiting qi, maintaining spirit, benefiting ears and eyes, lowering qi, widening intestines and invigorating stomach, contains bioflavonoids, multiple vitamins, 18 amino acids, crude protein, chlorophyll, selenium, zinc, magnesium, chromium, calcium and other mineral substances and trace elements, and has the effects of resisting oxidation, losing weight, beautifying, expelling toxin, beautifying, preventing and treating cardiovascular and cerebrovascular diseases, lowering blood pressure, reducing blood fat, reducing blood sugar and assisting in treating diabetes. Flos Sophorae Immaturus is flower and bud of Sophora japonica of Leguminosae, and contains abundant nutrients such as flavone, saponin, vitamins, minerals, and fatty acid with strong physiological activity with odd carbon number, and has effects of enhancing capillary toughness, preventing coronary arteriosclerosis, lowering blood pressure, improving myocardial circulation, resisting oxidation, resisting bacteria, and stopping bleeding.
It is worth mentioning that the rice protein mainly comprises albumin, globulin, alcohol-soluble protein, glutelin and other four proteins, has high biological value and high nutritional value, is low-antigen protein, does not generate anaphylactic reaction, has unique nutritional function, and can reduce the content of serum cholesterol.
The erythritol is a four-carbon sugar alcohol, has refreshing sweet taste with a slight cool feeling, low calorie and caries resistance, has extremely small influence on blood sugar concentration, and is an ideal sweetener.
The pectin forms are widely present in fruits, roots, stems and leaves of plants, are a component of cell walls, and exist along with cellulose to form an interlayer adhesive of adjacent cells, so that plant tissue cells are tightly adhered together. Has good gelling and emulsion stabilizing effects, and is an ideal thickener.
Plantago ovata forsk shells are shells of artificially planted plantago ovata forsk seeds in plantago of Plantaginaceae, are rich in soluble dietary fibers and insoluble dietary fibers, and can supplement dietary fibers, relax bowels, control weight, reduce cholesterol and reduce risks of cardiovascular and cerebrovascular diseases.
The conjugated linoleic acid glyceride powder in the formula is prepared by boiling, granulating, crushing and sieving conjugated linoleic acid glyceride, glucose syrup, sodium caseinate, potassium dihydrogen phosphate and silicon dioxide. Preferably, the mass ratio of the conjugated linoleic acid glyceride to the glucose syrup to the sodium caseinate to the potassium dihydrogen phosphate to the silicon dioxide is 11-13: 1-3: 2-4: 1-3: 0.5-1.5, the conjugated linoleic acid glyceride is prepared into powder after boiling granulation, the application convenience is greatly improved, and the flowability is also greatly improved.
It is worth mentioning that the conjugated linoleic acid glyceride is prepared by using safflower seed oil as a raw material, converting linoleic acid in the safflower seed oil into conjugated linoleic acid through conjugation reaction, and then esterifying the conjugated linoleic acid and glycerol. Has the effects of stimulating intestines and stomach, expelling toxin, reducing fat, increasing satiety, relieving constipation, and reducing weight.
The compound mineral in the formula is prepared by sieving and three-dimensionally mixing raw materials of calcium hydrophosphate, magnesium carbonate, sodium iron ethylene diamine tetraacetate, zinc gluconate and maltodextrin. Preferably, the mass ratio of calcium hydrophosphate, magnesium carbonate, sodium iron ethylene diamine tetraacetate, zinc gluconate and maltodextrin is 1-3: 3-5: 4-6: 2-3: 9 to 11.
The compound vitamin in the formula adopts L-sodium ascorbate, nicotinic acid, vitamin A acetate, D-calcium pantothenate, thiamine hydrochloride, pyridoxine hydrochloride, riboflavin, and vitamin D3The folic acid, the cyanocobalamin and the maltodextrin are taken as raw materials and are prepared by sieving, triple premixing and three-dimensional mixing. Preferably, the composition contains sodium L-ascorbate, nicotinic acid, vitamin A acetate, D-calcium pantothenate, thiamine hydrochloride, pyridoxine hydrochloride, riboflavin, and vitamin D3The mass ratio of folic acid to cyanocobalamin to maltodextrin is 42-46: 3-4: 2.5-3.5: 1.5-2.5: 0.4-0.6: 0.5-0.7: 0.4-0.5: 0.003-0.006: 0.06-0.09: 0.0005 to 0.0015: 90 to 110. Preferably, the mixing uniformity of the functional components is extremely high, and the sampling and measuring functions are carried out at different sampling pointsThe RSD value of the components is less than 0.6 percent.
The potato extract in the formula is prepared by the processes of crushing and size mixing of potatoes, ultrasonic-assisted enzymolysis, centrifugal filtration, ion exchange, membrane filtration, vacuum freeze drying and the like, so that a protease inhibitor in the extract is greatly protected from being damaged by extraction conditions such as temperature and the like, the purity of the inhibitor is greatly improved, the actual application effect is greatly improved, and the content of the protease inhibitor (PI 2) in the obtained extract is more than 58.6 g/kg.
It is worth mentioning that the potato extract is an all natural active protein extracted and enriched from potatoes, and can inhibit the activities of serine protease, trypsin and chymotrypsin (chymotrypsin), enhance the release of cholecystokinin (CCK), generate natural signals to be transmitted to the brain and induce satiety, and control hunger without any side effect, thereby achieving the efficacy of healthy weight management.
The plant powder in the formula is prepared by adopting the bitter gourd extract and the rhizoma alismatis extract and carrying out sieving and three-dimensional mixing process operations. Preferably, the mass ratio of the balsam pear extract to the alisma orientale extract is 1-2: 3 to 5.
It is worth mentioning that the balsam pear in the plant powder is a plant of the genus Momordica of the family Cucurbitaceae, is bitter in taste and cold in nature, and mainly has the functions of clearing away heat and toxic materials, reducing blood sugar, nourishing blood and nourishing liver; rhizoma Alismatis is dried tuber of rhizoma Alismatis of Alismaceae, and has sweet, bland and cold nature, and enters kidney and bladder channels, and has effects of promoting diuresis, eliminating dampness, clearing heat, eliminating turbid pathogen and reducing blood lipid.
From the above description, it can be understood by those skilled in the art that the diet composition for meal replacement for weight loss uses high-quality fat, carbohydrate and protein for meal replacement, can accurately quantify the nutrient intake and prevent excessive intake, wherein the high-quality fat is derived from the composite oil microcapsules and the conjugated linoleic acid glyceride powder, the high-quality carbohydrate is derived from the grain powder and the erythritol, and the high-quality protein is derived from the rice protein and the grain powder. In addition, the weight management and weight losing effects of the diet composition are enhanced by using the functional components of the gynostemma pentaphylla micro-capsules, the white kidney bean extract and the wheat oligopeptide, wherein the functional components are derived from the compound traditional Chinese medicine micro-capsules, the traditional Chinese medicine extract, the potato extract and the plant powder. In addition, the cereal powder and the compound fruit powder are used as vitamin and mineral sources to meet the requirement of daily required vitamins and minerals, wherein the vitamin and mineral sources are as follows: cereal powder, compound mineral substances and compound vitamins. In addition, dietary fiber and prebiotics are used for regulating intestinal health, promoting proliferation of probiotics, improving intestinal micro-ecological environment, reducing fat absorption and promoting intestinal emptying, wherein the dietary fiber is derived from Plantago ovata husk powder, polydextrose and pectin, and the prebiotics are derived from polydextrose.
In addition, the diet-cutoff composition for weight-losing meal replacement strictly screens traditional Chinese medicines and food raw materials with extremely small toxic and side effects, achieves the effect of improving the intestinal function without damaging organs, mildly conditions and expels toxin, reduces blood fat and loses weight, and therefore the function specification of weight management and weight-losing meal replacement is practically realized.
Therefore, the diet-cutoff composition for weight-losing meal replacement has the advantages that functional factors in the components are definite in direction and are designed in a full-nutrition mode, the basic metabolism level is improved, the accumulation of chronic inflammation is reduced, the composition can be used for comprehensively replacing other foods except complementary foods such as fruits and vegetables, the fat is combusted in an auxiliary mode, the hunger sensation is inhibited, the high satiety is provided, the composite dietary fiber and prebiotics are rich, the gastrointestinal tract function can be effectively improved, the mild conditioning effect is realized, and the toxin expelling and the lipid lowering effect are realized.
According to another aspect of the present invention, the present invention provides a method for preparing a diet composition for a diet substitute, wherein the method for preparing the diet composition for the diet substitute comprises the following steps:
the composition comprises the following components in parts by weight:
12-20 parts of cereal powder
10-16 parts of polydextrose
7-16 parts of composite oil microcapsule
2-8 parts of composite traditional Chinese medicine microcapsules
2-5 parts of traditional Chinese medicine extract
5-12 parts of rice protein
13-22 parts of erythritol
1-4 parts of pectin
3-9 parts of plantain seed shell powder
4-10 parts of conjugated linoleic acid glyceride powder
0.5-1.5 parts of composite mineral
0.1-0.5 part of compound vitamin
0.4-1 part of potato extract
5-10 parts of plant powder
Uniformly mixing for 15-25 min in a three-dimensional mixer, wherein the running frequency of the mixer is 18-30 Hz.
Further, before mixing, the preparation method of the diet composition for the diet replacement comprises the following steps:
preparing a cereal flour, wherein said cereal flour is prepared by a method comprising: selecting millet, sorghum, mung bean, barley, coix seed and hulless oat as raw materials, and processing by grain germination technology, microwave drying, low-temperature superfine grinding technology, enzymolysis emulsification, spray drying and other technologies to prepare grain powder; more specifically, the method of preparing a cereal flour comprises:
(A) grain germination: weighing barley and hulless oat in the mass ratio, soaking the barley and the hulless oat in purified water for 18-24 hours, taking out the barley and the hulless oat, draining the water, placing the barley and the hulless oat in a constant-temperature constant-humidity germination room for germination, wherein the temperature is constant at 21 +/-1 ℃, the relative humidity is constant at 85 +/-2%, the germination time is 72-96 hours, removing roots, and cleaning the barley and the hulless oat for later use;
(B) microwave drying: performing microwave drying on the barley germs and the hulless oat germs obtained in the step (A), wherein the microwave power is 20-40 Kw, the drying temperature is kept at 70-80 ℃, and the drying time is 120-150 min;
(C) and (3) low-temperature superfine grinding: mixing millet, sorghum, mung bean, barley germ, coix seed and hulless oat germ according to the mass ratio, putting into a low-temperature superfine grinding device for superfine grinding, and sieving with a 500-mesh sieve to obtain grain superfine powder;
(D) performing enzymolysis and emulsification, namely putting the ultrafine grain powder into purified water of which the weight is 12-16 times, uniformly stirring to prepare a dispersion, heating and heating to keep the temperature of the dispersion at 50 +/-2 ℃, adding β -amylase into the dispersion, uniformly stirring and performing enzymolysis for 1.5-2.5 hours, wherein the adding amount of β -amylase is 0.4-0.8% of the content of a substrate, adjusting the pH to 2.5-4.5, adding pectinase into the dispersion, uniformly stirring and performing enzymolysis for 2.0-2.5 hours at 50 +/-3 ℃, wherein the adding amount of the pectinase is 0.25-0.4% of the content of the substrate, adjusting the pH to 7.5-8.5, adding trypsin into the dispersion, uniformly stirring and performing enzymolysis for 1.5-2.5 hours at 37 +/-1 ℃, wherein the adding amount of the trypsin is 0.35-0.65% of the content of the substrate, and performing enzyme inactivation by using a high-temperature instant enzyme method after the enzymolysis is finished;
(E) and (3) concentrating under reduced pressure: concentrating the clear liquid under reduced pressure, controlling the concentration temperature to be 70-75 ℃, controlling the vacuum degree to be-0.08-0.095 Mpa, and controlling the relative density to be 1.05-1.08 to obtain an extract;
(F) spray drying: and sterilizing and filtering the extract, and then spray-drying, wherein the process parameters are that the nozzle temperature is 175-182 ℃, the outlet temperature is 85-90 ℃, and the feeding speed is 2.5-3.0L/min, so as to obtain the cereal powder.
Furthermore, the grain powder in the preparation method of the grain powder is subjected to the technical treatment of grain germination technology, microwave drying, low-temperature ultramicro crushing technology, enzymolysis emulsification, spray drying and the like, so that the full wall breaking and enzymolysis of the grain are completed, the digestibility of human bodies to the nutritional ingredients of the grain is greatly increased, the contents of oligopeptide, amino acid and gamma-aminobutyric acid are greatly improved, and the content of the gamma-aminobutyric acid reaches 480-1380 mg/kg.
The preparation method of the diet composition for weight loss meal replacement comprises the steps of preparing the compound oil microcapsules, wherein the preparation method of the compound oil microcapsules comprises the following steps:
selecting poppy seed oil, antarctic krill oil, red date polysaccharide, tremella polysaccharide, rosemary extract, gamma-cyclodextrin, sucrose fatty acid ester, sodium alginate and pectin as raw materials, and preparing the composite oil microcapsule by microcapsule double-layer embedding and spray drying process technology; specifically, the method for preparing the composite oil microcapsule comprises the following steps:
(a) preparing a first wall material/core material solution: uniformly stirring the poppy seed oil and the antarctic krill oil in the mass ratio to obtain a mixed oil core material solution, uniformly mixing the red date polysaccharide, the rosemary extract, the gamma-cyclodextrin and the sucrose fatty acid ester, adding a proper amount of water, fully stirring and dissolving to obtain a wall material solution with the mass fraction (m/m) of 25-30%, wherein the mass ratio of the red date polysaccharide to the rosemary extract to the gamma-cyclodextrin to the sucrose fatty acid ester is 7-9: 0.4-0.6: 9-11: 0.5 to 1.5;
(b) one layer of embedding: mixing the oil core material solution and the wall material solution in the step (a) according to a mass ratio of 2-3: 3-5, emulsifying and homogenizing for 8-12 min at a rotating speed of 2500-3500 r/min by using an emulsifying homogenizer, standing for 3h, separating a water outlet layer by using an oil-water separator, discarding, and collecting an oil layer for later use;
(c) preparing a second wall material/core material solution: taking the oil layer in the step (b) as a second core material solution, uniformly mixing the tremella polysaccharide, sodium alginate, gamma-cyclodextrin and pectin, adding a proper amount of water, and fully stirring and dissolving to prepare a wall material solution with the mass fraction (m/m) of 30-35%, wherein the mass ratio of the tremella polysaccharide to the sodium alginate to the gamma-cyclodextrin to the pectin is 10-12: 0.5-1.5: 9-13: 1-3;
(d) two-layer embedding: mixing the second core material solution and the wall material solution in the step (c) according to a mass ratio of 1.5: 1-2.5, and continuously stirring for 10-15 min to prepare a secondary embedding solution;
(e) spray drying: and (d) carrying out spray drying on the secondary embedding liquid in the step (d), wherein the technological parameters are that the nozzle temperature is 180-185 ℃, the outlet temperature is 85-95 ℃, and the feeding speed is 2.5-3.0L/min, so as to obtain the composite oil microcapsule.
Further, the red date polysaccharide (tremella polysaccharide) in the steps (a) and (c) can be prepared by the following steps:
carrying out enzymolysis: taking crushed red date ultrafine powder (tremella ultrafine powder), adding water which is 15-45 times of the weight of the materials and 1.0-2.5% of pectinase, performing enzymolysis for 50-90 min at a constant temperature of 45-55 ℃, and heating to above 95 ℃ to inactivate the enzyme;
(II) extraction: carrying out heat preservation extraction at the temperature of 95-100 ℃, filtering by using a 500-mesh screen to obtain a red date polysaccharide (tremella polysaccharide) extracting solution, wherein the extracting times are 1-2 times, and the extracting time is 1-3 hours each time;
(III) ion exchange: performing impurity removal and decoloration treatment on the filtered red date polysaccharide (tremella polysaccharide) extract through an ion exchange column and an active carbon column;
(IV) vacuum concentration: carrying out vacuum concentration on the solution after ion exchange, wherein the concentration temperature is 65-85 ℃, and the vacuum degree is-0.075-0.095 Mpa, so as to obtain a red date polysaccharide concentrated solution (tremella polysaccharide concentrated solution), and the relative density is controlled to be 1.03-1.05;
(V) vacuum freeze drying: the red date polysaccharide concentrated solution (tremella polysaccharide concentrated solution) is prepared into red date polysaccharide powder (tremella polysaccharide powder) through a vacuum freeze drying technology, wherein the pre-freezing initial temperature is-38 ℃ to-48 ℃, the pre-freezing speed is 0.3-0.6 ℃/min, the pre-freezing final temperature is-75 ℃, the pressure of a drying chamber is 45-110 pa, the temperature of a heating plate is 35-45 ℃, and the drying time is 20-26 h.
The red date polysaccharide (tremella polysaccharide) is prepared by the preparation method, and the extraction rate of the polysaccharide is as high as more than 50% (more than 36%).
Furthermore, the microcapsule double-layer embedding and spray drying technology is adopted in the technology for preparing the composite oil microcapsule, so that the quality guarantee period and stability of the oil are greatly prolonged, and the quality of the product is greatly improved. The embedding rate of the composite oil microcapsule is up to more than 95%, and the particle size is 230-380 mu m. The obtained composite oil microcapsule has good emulsifying property and good stability to light and heat.
The preparation method of the diet-depriving composition for weight-losing meal replacement comprises the following steps:
preparing a composite traditional Chinese medicine microcapsule, wherein the preparation method of the composite traditional Chinese medicine microcapsule comprises the following steps:
selecting cortex Cinnamomi, fructus Juniperi, α -cyclodextrin, sodium alginate, and silicon dioxide as raw materials, and subjecting to supercritical CO2Extraction and microcapsule embedding integrated forming technology; specifically, the preparation method of the composite traditional Chinese medicine microcapsule comprises the following stepsThe method comprises the following steps:
(G) supercritical CO2And (3) extraction: sieving coarse powder of cinnamon and juniper berries by a 6-8-mesh sieve, and then sieving the coarse powder with CO2Extracting by supercritical extraction (extraction temperature is 35-42 ℃, extraction pressure is 32-38 Mpa, CO is2The flow rate is 9-15 kg/h, the extraction time is 120-150 min, the separation pressure is 4-5MPa, the separation temperature is 35-40 ℃, and oily extracts of cinnamon and juniper berries are obtained through separation;
(H) and (3) carrying out microcapsule embedding integrated forming, namely weighing α -cyclodextrin, sodium alginate and silicon dioxide in proper amount before the step (G) is started, uniformly mixing the α -cyclodextrin, the sodium alginate and the silicon dioxide, placing the mixture on the bottom layer of a separation kettle of a supercritical extraction device for carrying out microcapsule embedding integrated forming, wherein the mass ratio of α -cyclodextrin, the sodium alginate and the silicon dioxide is 7-9: 1-2: 0.2-1.0, the total amount of the mixed powder of the three is 5-10% of the total amount of coarse powder of cinnamon and juniper seeds, heating the extracted oil of the cinnamon and the juniper seeds at the top of the extraction kettle, reducing the pressure to 4-5MPa in the separation kettle2After separation, the CO enters from the top side part of the separation kettle2The total storage tank is recycled, oily cinnamon and juniper berry extracts form a sinking cyclone in a separation kettle through a vortex flow guide air port, the sinking cyclone, α -cyclodextrin, sodium alginate and silicon dioxide powder are fully mixed and embedded in the separation kettle under the action of high-pressure airflow to prepare composite traditional Chinese medicine microcapsule powder, the composite traditional Chinese medicine microcapsule powder is formed in one step, the loss and the loss of functional components of an embedding object caused by a spray drying process are avoided, the process is compressed, the cost is saved, and inert gas CO is filled in the separation embedding kettle2Protection, cyclone embedding in low temperature environment, no temperature rise process, and avoidance of oxidative decomposition of effective components.
Furthermore, the preparation method of the composite traditional Chinese medicine microcapsule adopts supercritical CO2The extraction and microcapsule embedding integrated forming technology saves a large amount of time, energy and cost, the embedding rate of the effective components in the composite traditional Chinese medicine microcapsule reaches more than 90%, and the particle size is 100-230 microns. The obtained composite traditional Chinese medicine microcapsule has good solubility and good stability to light and heat. CO 22The supercritical extraction method can extract multiple components with wide polarity range, and the cortex Cinnamomi and fructus Juniperi extract prepared by the method is more traditional alcohol extraction methodThe one-step forming process operation abandons the traditional alcohol extraction process which needs concentration and spray drying, the extraction time is greatly shortened by more than 50 percent, and the extraction yield is improved by more than 30 percent.
The preparation method of the diet composition for weight loss meal replacement comprises the following steps of preparing traditional Chinese medicine extract microcapsules, wherein the preparation method of the traditional Chinese medicine extract microcapsules comprises the following steps:
selecting tartary buckwheat and sophora flower as raw materials, carrying out coarse powder, ultrasonic alcohol extraction, concentration, column chromatography refining and spray drying; specifically, the method for preparing the traditional Chinese medicine extract comprises the following steps:
(I) coarse powder: sieving the coarse powder of the tartary buckwheat and the sophora flower in the mass ratio by a sieve of 6-8 meshes;
(J) ultrasonic alcohol extraction: putting the coarse powder of the tartary buckwheat and the sophora flower in the step (I) into an extraction reflux tank, injecting 55-65% (v/v) of ethanol solution as an ethanol extraction solvent, extracting for 3 times at a constant temperature of 60-80 ℃ with the extraction time of 0.5-1 h each time, and performing ultrasonic-assisted ethanol extraction with the ultrasonic power of 200-500 w to obtain traditional Chinese medicine ethanol extract;
(K) and (3) centrifugal concentration: centrifuging the traditional Chinese medicine alcohol extract obtained in the step (J) to remove impurities, wherein the centrifugal rotating speed is 14000-16000 r/min, and the feeding speed is 2.0-3.0L/min, so as to obtain traditional Chinese medicine alcohol extract supernatant; concentrating the supernatant of the traditional Chinese medicine alcohol extraction in vacuum, volatilizing the solvent, and concentrating until the relative density is 1.03-1.05, the concentration temperature is 65-75 ℃, and the vacuum degree is kept at-0.08 to-0.095 Mpa to obtain a traditional Chinese medicine extraction concentrated solution;
(L) column-passing refining: passing the concentrated solution of the traditional Chinese medicine extraction in the step (K) through macroporous resin, and collecting traditional Chinese medicine effluent liquid with high effective component flavone;
(M) spray drying: and (4) carrying out spray drying on the traditional Chinese medicine effluent liquid in the step (L) to prepare traditional Chinese medicine extract powder, wherein the technological parameters are that the nozzle temperature is 175-185 ℃, the outlet temperature is 80-92 ℃, and the feeding speed is 2.0-2.5L/min.
Furthermore, the traditional Chinese medicine extract in the method for preparing the traditional Chinese medicine extract adopts the technological operations of ultrasonic alcohol extraction, concentration, column-passing refining, spray drying and the like, so that the functional components such as flavone and the like in tartary buckwheat and sophora flower are perfectly maintained, the edible amount is reduced, and the bioavailability is improved. Preferably, the total flavone content of the traditional Chinese medicine extract is improved by more than 50% compared with that of the traditional alcohol extraction method.
The preparation method of the diet composition for weight loss meal replacement comprises the steps of preparing conjugated linoleic acid glyceride powder, wherein the preparation method of the conjugated linoleic acid glyceride powder comprises the following steps: selecting conjugated linoleic acid glyceride, glucose syrup, sodium caseinate, potassium dihydrogen phosphate and silicon dioxide, boiling, granulating, crushing and sieving;
the conjugated linoleic acid glyceride powder can be prepared by the following steps:
(f) boiling and granulating: weighing sodium caseinate, monopotassium phosphate and silicon dioxide according to the mass ratio, putting into a boiling granulator, mixing for 5-10 min by blowing, mixing the conjugated linoleic acid glyceride and the glucose syrup in the mass fraction, feeding by a peristaltic pump at a feeding speed of 1.0-2.0L/min, fully mixing the oil agent and the powder, and granulating for 30-60 min;
(g) crushing and sieving: and (3) crushing large particles subjected to boiling granulation into small particles, and screening the small particles by using a disc vibrating screen with the mesh number of 60-80 meshes.
Furthermore, the conjugated linoleic acid glyceride powder is prepared into powder by adopting a preparation process of boiling granulation, crushing and sieving, so that the application convenience is greatly improved, and the flowability is also greatly improved.
The preparation method of the diet composition for weight loss meal replacement comprises the following steps of preparing the compound mineral, wherein the preparation method of the compound mineral comprises the following steps:
sieving calcium hydrogen phosphate, magnesium carbonate, sodium ferric ethylenediamine tetraacetate, zinc gluconate and maltodextrin, and three-dimensionally mixing;
the composite mineral can be prepared by the following steps:
(h) sieving: weighing calcium hydrogen phosphate, magnesium carbonate, sodium iron ethylene diamine tetraacetate, zinc gluconate and maltodextrin according to the mass ratio, and completely sieving by a disc vibrating screen, wherein the mesh number of the screen is 60-100 meshes;
(i) three-dimensional mixing: and (d) putting the sieved powder in the step (h) into a three-dimensional mixer for three-dimensional mixing, wherein the mixing time is 25-30 min, and the mixing frequency is 20-25 Hz, so as to prepare the composite mineral substance for later use.
The preparation method of the diet composition for weight loss meal replacement comprises the following steps of preparing the compound vitamin, wherein the preparation method of the compound vitamin comprises the following steps:
selecting L-ascorbic acid sodium, nicotinic acid, vitamin A acetate, D-calcium pantothenate, thiamine hydrochloride, pyridoxine hydrochloride, riboflavin, and vitamin D3Sieving folic acid, cyanocobalamine and maltodextrin as raw materials, triple premixing and three-dimensional mixing;
specifically, the multivitamin can be prepared by the following steps:
(j) sieving: weighing the sodium L-ascorbate and the maltodextrin in the mass fraction for later use; weighing the nicotinic acid, the vitamin A acetate, the D-calcium pantothenate, the thiamine hydrochloride, the pyridoxine hydrochloride, the riboflavin and the vitamin D according to the mass fraction3Uniformly sieving folic acid and cyanocobalamine with a disk vibrating sieve to obtain vitamin sieving powder, wherein the mesh number of the sieve is 80-100 meshes;
(k) triple premixing: putting the vitamin sieving powder obtained in the step (j) and maltodextrin with the same weight as the vitamin sieving powder into a small three-dimensional mixer for three-dimensional premixing, wherein the mixing time is 10-15 min, and the mixing frequency is 15-20 Hz; repeating the above operations twice according to an equivalent incremental method, adding maltodextrin with the same weight as the mixed powder each time for premixing, and repeating the above operations twice;
(l) Three-dimensional mixing: and (e) uniformly placing the triple premixed powder obtained in the step (k), the L-sodium ascorbate and the rest maltodextrin in a three-dimensional mixer for three-dimensional mixing, wherein the mixing time is 20-35 min, and the mixing frequency is 18-25 Hz, so as to prepare the compound vitamin for later use.
Furthermore, because the preparation process of sieving, triple premixing and three-dimensional mixing is adopted in the preparation process of the compound vitamin, the mixing uniformity of the effective components is particularly high as the optimization, and the RSD values of the effective component contents sampled and measured at different sampling points are all less than 0.6%.
The preparation method of the diet composition for weight loss meal replacement comprises the step of preparing the potato extract, wherein the preparation method of the potato extract comprises the following steps: selecting potatoes, and carrying out processes such as crushing and size mixing, ultrasonic-assisted enzymolysis, centrifugal filtration, ion exchange, membrane filtration, vacuum freeze drying and the like to prepare the potato starch; in particular, the potato extract can be prepared by the following steps:
(m) crushing and size mixing: cleaning and peeling fresh potatoes, adding purified water with the weight 30-40 times that of the materials, fully stirring and crushing the materials into potato pulp, and adjusting the pH value to 4.0;
(n) carrying out ultrasonic-assisted enzymolysis, namely adding pectinase accounting for 0.5-2% of the weight of the potato pulp and α -amylase accounting for 1-1.5% of the weight of the potato pulp into the potato pulp prepared in the step (m), carrying out enzymolysis for 60-90min at a constant temperature of 45-50 ℃, and improving enzymolysis efficiency by ultrasonic-assisted enzymolysis with the ultrasonic power of 100-200W;
(o) centrifugal filtration: centrifuging the enzymolysis liquid prepared in the step (n) to remove impurities, keeping the centrifugal rotation speed of 13000-17000 r/min and the feeding speed of a peristaltic pump of 2.2-3.3L/min, and collecting supernatant;
(d) ion exchange: performing impurity removal, decoloration and deodorization treatment on the enzymolysis supernatant prepared in the step (o) by an ion exchange column and an activated carbon column;
(p) membrane filtration: starting membrane filtration equipment, filtering the supernatant through a microporous filter membrane, wherein the thickness of the filter membrane is 120-160 mu m, the filtered particle size is 8-20 mu m, the operating pressure is 0.05-0.45 MPa, and collecting protein filter residues;
(q) vacuum freeze drying: and (d) preparing the protein filter residue prepared in the step (p) into a potato extract by a vacuum freeze drying technology, wherein the pre-freezing initial temperature is-40 to-45 ℃, the pre-freezing speed is 0.3 to 0.4 ℃/min, the pre-freezing final temperature is-75 ℃, the pressure of a drying chamber is 7 to 110pa, the temperature of a heating plate is 35 to 45 ℃, and the drying time is 20 to 24 hours.
Furthermore, the potato extract in the preparation of the potato extract is subjected to ultrasonic-assisted enzymolysis, centrifugal filtration, ion exchange, membrane filtration and vacuum freeze drying, so that the protease inhibitor in the extract is greatly protected from being damaged by extraction conditions such as temperature and the like, the purity of the inhibitor is greatly improved, the actual application effect is greatly improved, and the content of the protease inhibitor (PI 2) in the obtained extract is more than 58.6 g/kg.
The preparation method of the diet composition for weight loss meal replacement comprises the following steps of preparing plant powder:
selecting bitter gourd extract and rhizoma alismatis extract, and performing sieving and three-dimensional mixing process operation to obtain the bitter gourd extract and rhizoma alismatis extract; specifically, the prepared plant powder can be prepared by the following steps:
(x) Sieving: weighing corresponding amounts of the bitter gourd extract and the rhizoma alismatis extract according to the mass fraction, and sieving the bitter gourd extract and the rhizoma alismatis extract by a disc vibrating screen to obtain a powder with 90-110 meshes;
(y) three-dimensional mixing: and (d) putting the screened extract obtained in the step (x) into a three-dimensional mixer for three-dimensional mixing, wherein the mixing time is 20-25 min, and the mixing frequency is 20-30 Hz, so as to obtain the plant powder for later use.
In the first embodiment of the invention, 18 parts of cereal powder, 13 parts of composite oil microcapsules, 6 parts of composite traditional Chinese medicine microcapsules, 4 parts of traditional Chinese medicine extract, 6 parts of conjugated linoleic acid glyceride powder, 1 part of composite mineral substance, 0.2 part of composite vitamin, 0.8 part of potato extract, 5 parts of plant powder, 10 parts of polydextrose, 8 parts of rice protein, 21 parts of erythritol, 2 parts of pectin, 5 parts of Plantago ovata husk powder and other raw materials are weighed and uniformly mixed for 20min by using a three-dimensional mixer, the operation frequency is 24Hz, and the mixture is taken out to obtain the required diet-cutting composition.
In the second embodiment of the invention, 12 parts of prepared cereal powder, 14 parts of prepared composite oil microcapsules, 8 parts of prepared composite traditional Chinese medicine microcapsules, 5 parts of prepared traditional Chinese medicine extract, 10 parts of prepared conjugated linoleic acid glyceride powder, 1.5 parts of prepared composite mineral substance, 0.5 part of prepared vitamin complex, 1 part of prepared potato extract, 8 parts of prepared plant powder, 15 parts of polydextrose, 5 parts of prepared rice protein, 14 parts of prepared erythritol, 2 parts of prepared pectin, 4 parts of prepared Plantago ovata seed husk powder and other raw materials are uniformly mixed for 15min by using a three-dimensional mixer, the operation frequency is 18Hz, and the mixture is taken out to obtain the required diet-cutting composition.
In the third embodiment of the invention, 20 parts of prepared cereal powder, 8 parts of prepared composite oil microcapsules, 4 parts of prepared composite traditional Chinese medicine microcapsules, 2 parts of prepared traditional Chinese medicine extract, 8 parts of prepared conjugated linoleic acid glyceride powder, 1.2 parts of prepared composite mineral substance, 0.3 part of prepared vitamin complex, 0.5 part of prepared potato extract and 10 parts of prepared plant powder are weighed and uniformly mixed for 25min by using a three-dimensional mixer together with 16 parts of polydextrose, 9 parts of prepared rice protein, 15 parts of prepared erythritol, 3 parts of prepared pectin, 3 parts of prepared Plantago ovata seed husk powder and other raw materials, wherein the operation frequency is 30Hz, and the mixture is taken out to obtain the diet-breaking composition for weight-losing meal replacement.
Human body sample for test eating: using the diet composition for a diet substitute prepared according to the third example as a sample for a meal, the population recommended the consumption of the diet composition 1 time a day, 1 bag each time, and 20g of the diet composition for a dinner.
1. Inclusion subject criteria: subjects who met the following criteria and participated voluntarily.
The age is more than or equal to 18 years and less than or equal to 55 years;
the body mass index BMI is 24-35 kg/m or the waist size of a male person is larger than 90cm, and the waist size of a female person is larger than 85 cm;
no history of chronic diseases such as diabetes, coronary arteriosclerotic heart disease, liver and kidney dysfunction, and the like;
voluntarily attend the trial and sign an informed consent.
2. Exclusion criteria:
alcohol or drug abuse;
(ii) a psychiatric disorder;
people who are receiving drug for weight loss;
precursor weight change greater than 5% for 3 months;
undergoing metabolic surgery;
smoking habits changed within 6 months or were planned to quit smoking 21 days in the future.
3. The experimental process comprises the following steps:
the subject takes the meal as follows: 3 weeks; a lead-in period: 0-7 days; the total planning time length is as follows: 4 weeks
4. General conditions are as follows:
the initial test population eats 40 cases, and the subjects have normal mental, sleep and diet states before and after the test, and no abnormal phenomenon occurs. Examples, gender, population, age distribution are shown in Table 1 below.
TABLE 1 comparison of general data of volunteers before tasting
Age group | Number of people | For male | Woman |
Under 20 years old | 1 | 1 | 0 |
20-30 years old | 13 | 7 | 6 |
30-40 years old | 14 | 6 | 8 |
40-50 years old | 10 | 4 | 6 |
50-60 years old | 2 | 1 | 1 |
Total of | 40 | 19 | 21 |
5. The test method comprises the following steps:
the test group takes the diet composition for weight-losing meal replacement prepared in the third embodiment, the recommended daily consumption of people is 1 time per day, 1 bag per time, and the meal is taken in supper time, and the total daily consumption is 20 g; after four weeks, the change of the body fat rate, the body weight, the waist circumference and other data is measured before and after the test, and the statistical data is comprehensively analyzed.
6. And (3) test results:
the results data pairs for volunteers after the test are shown in table 2:
TABLE 2 comparison of the results of volunteers after test feeding
Total number of people | Number of effective persons | Poor body fat percentage% | Effective rate% | Mean weight loss kg | Average waist reduction value cm | |
Health uniform balance | 2 | 2 | 0.4 | 100 | 1.9 | 4.5 |
Excessive fat | 5 | 5 | 1.3 | 100 | 2.8 | 5.4 |
Mild obesity | 18 | 16 | 2.0 | 88.89 | 3.6 | 4.3 |
Moderate obesity | 12 | 12 | 1.9 | 100 | 5.2 | 5.6 |
Severe obesity | 3 | 3 | 0.9 | 100 | 5.9 | 3.8 |
Total/average | 40 | 38 | 1.3 | 95 | 3.88 | 4.72 |
The results in table 2 show that the total effective rate of the test group is 95%, the body fat percentage, the weight loss and the waist circumference are obviously reduced, and volunteers in the test group have no obvious adverse reaction, so that the test proves that the diet composition for weight-losing meal replacement has good weight management and weight-losing meal replacement functions.
It will be appreciated by persons skilled in the art that the embodiments of the invention described above are given by way of example only and are not limiting of the invention. The objects of the invention have been fully and effectively accomplished. The functional and structural principles of the present invention have been shown and described in the examples, and any variations or modifications of the embodiments of the present invention may be made without departing from the principles.
Claims (10)
1. A diet composition for weight loss meal replacement comprising:
12-20 parts of cereal powder
10-16 parts of polydextrose
7-16 parts of composite oil microcapsule
2-8 parts of composite traditional Chinese medicine microcapsules
2-5 parts of traditional Chinese medicine extract
5-12 parts of rice protein
13-22 parts of erythritol
1-4 parts of pectin
3-9 parts of plantain seed shell powder
4-10 parts of conjugated linoleic acid glyceride powder
0.5-1.5 parts of composite mineral
0.1-0.5 part of compound vitamin
0.4-1 part of potato extract
5-10 parts of plant powder.
2. The diet composition for weight-reducing meal replacement according to claim 1, wherein the grain powder is implemented as plant nutrition powder integrated by germination, microwave drying, low-temperature superfine grinding, enzymolysis emulsification and spray drying, wherein the mass ratio of millet, sorghum, mung beans, barley, coix seeds and hulless oats is 1-2: 1-3: 3-5: 1-2: 2-4, and the content of gamma-aminobutyric acid is 480-1380 mg/kg.
3. The delicacy composition for weight-reducing meal replacement according to claim 2, wherein the composite oil microcapsules are prepared by taking poppy seed oil, euphausia superba oil, red date polysaccharide, tremella polysaccharide, rosemary extract, gamma-cyclodextrin, sucrose fatty acid ester, sodium alginate and pectin as raw materials and performing microcapsule double-layer embedding and spray drying, wherein the mass ratio of the poppy seed oil to the euphausia superba oil is 3-4: 1-3, the embedding rate of the composite oil microcapsule is up to more than 95%, and the particle size of the composite oil microcapsule is 230-380 μm.
4. The diet composition for weight-losing meal replacement according to claim 1, wherein the traditional Chinese medicine extract adopts the raw materials of tartary buckwheat and sophora flower in a mass ratio of 2-3.5: 1-2.5; the conjugated linoleic acid glyceride powder is prepared from the following raw materials in parts by mass, namely, the conjugated linoleic acid glyceride, glucose syrup, sodium caseinate, potassium dihydrogen phosphate and silicon dioxide, wherein the mass ratio of the conjugated linoleic acid glyceride powder to the glucose syrup to the sodium caseinate to the potassium dihydrogen phosphate to the silicon dioxide is 11-13: 1-3: 2-4: 1-3: 0.5 to 1.5; the composite mineral substance is prepared from calcium hydrophosphate, magnesium carbonate, sodium iron ethylene diamine tetraacetate, zinc gluconate and maltodextrin, wherein the mass ratio of the calcium hydrophosphate to the magnesium carbonate to the sodium iron ethylenediamine tetraacetate to the zinc gluconate to the maltodextrin is 1-3: 3-5: 4-6: 2-3: 9-11; wherein the compound vitamin adopts raw materials of L-sodium ascorbate and tobaccoAcid, vitamin A acetate, D-calcium pantothenate, thiamine hydrochloride, pyridoxine hydrochloride, riboflavin, and vitamin D3Folic acid, cyanocobalamine and maltodextrin, wherein the mass ratio of folic acid to cyanocobalamine to maltodextrin is 42-46: 3-4: 2.5-3.5: 1.5-2.5: 0.4-0.6: 0.5-0.7: 0.4-0.5: 0.003-0.006: 0.06-0.09: 0.0005 to 0.0015: 90-110; wherein the plant powder adopts balsam pear extract and rhizoma alismatis extract which are raw materials, and the mass ratio of the balsam pear extract to the rhizoma alismatis extract is 1-2: 3 to 5.
5. The preparation method of the diet composition for the diet substitute is characterized by comprising the following steps of:
(S1) processing semen setariae, jowar, semen phaseoli radiati, fructus Hordei vulgaris, semen Coicis, and herba Avenae Fatuae by germination, microwave drying, low-temperature micronization, enzymolysis, emulsification, and spray drying to obtain cereal powder;
(S2) preparing compound oil microcapsules by using poppy seed oil, antarctic krill oil, red date polysaccharide, tremella polysaccharide, rosemary extract, gamma-cyclodextrin, sucrose fatty acid ester, sodium alginate and pectin as raw materials through microcapsule double-layer embedding and spray drying technology;
(S3) processing cortex Cinnamomi, fructus Juniperi, α -cyclodextrin, sodium alginate, and silicon dioxide by supercritical CO2Extracting and microcapsule embedding to obtain composite Chinese medicinal microcapsule;
(S4) processing radix Et rhizoma Fagopyri Tatarici and flos Sophorae Immaturus into coarse powder, extracting with ultrasonic ethanol, concentrating, refining with column chromatography, and spray drying to obtain Chinese medicinal extract;
(S5) boiling and granulating conjugated linoleic acid glyceride, glucose syrup, sodium caseinate, potassium dihydrogen phosphate and silicon dioxide, crushing and sieving to prepare conjugated linoleic acid glyceride powder;
(S6) sieving and three-dimensional mixing calcium hydrogen phosphate, magnesium carbonate, sodium iron ethylene diamine tetraacetate, zinc gluconate and maltodextrin to prepare the compound mineral;
(S7) adopts L-sodium ascorbate, nicotinic acid, vitamin A acetate, D-calcium pantothenate, thiamine hydrochloride, and pyriproxyfen hydrochloridePyridoxine, riboflavin, vitamin D3Sieving folic acid, cyanocobalamine and maltodextrin as raw materials, triple premixing and three-dimensional mixing to prepare the compound vitamin;
(S8) preparing potato extract from potatoes by crushing and size mixing, ultrasonic-assisted enzymolysis, centrifugal filtration, ion exchange, membrane filtration and vacuum freeze drying;
(S9) preparing plant powder by sieving the bitter gourd extract and the alisma orientale extract and performing three-dimensional mixing process operation;
(S10) uniformly mixing the prepared cereal powder, composite oil microcapsules, composite traditional Chinese medicine microcapsules, traditional Chinese medicine extracts, conjugated linoleic acid glyceride powder, composite mineral substances, composite vitamins, potato extracts and plant powder with the polydextrose, rice protein, erythritol, pectin and Plantago ovata seed husk powder for 15-25 min by using a three-dimensional mixer, wherein the operation frequency is 18-30 Hz, and taking out the mixture to obtain the required diet-stopping composition.
6. The method of preparing the diet composition for slimming meal replacement according to claim 5, wherein the method of preparing the diet composition for slimming meal replacement comprises preparing a cereal flour, wherein preparing the cereal flour comprises the steps of:
(Y1) germination of the grain: weighing barley and hulless oat, soaking the barley and the hulless oat in purified water for 18-24 hours, taking out the barley and the hulless oat, draining the water, placing the barley and the hulless oat in a constant-temperature constant-humidity germination room for germination, wherein the temperature is constant at 21 +/-1 ℃, the relative humidity is constant at 85 +/-2%, the germination time is 72-96 hours, removing roots, and cleaning for later use;
(Y2) microwave drying: performing microwave drying on the barley germs and the hulless oat germs obtained in the step (Y1), wherein the microwave power is 20-40 Kw, the drying temperature is kept at 70-80 ℃, and the drying time is 120-150 min;
(Y3) carrying out low-temperature ultrafine grinding: uniformly mixing millet, sorghum, mung bean, barley germ, coix seed and hulless oat germ, putting into a low-temperature superfine grinding device for superfine grinding, and sieving with a 500-mesh sieve to obtain grain superfine powder;
(Y4) carrying out enzymolysis and emulsification, namely putting the ultrafine grain powder into purified water of which the temperature is 12-16 times, uniformly stirring to prepare a dispersion, heating to raise the temperature and keep the temperature at 50 +/-2 ℃, adding β -amylase into the dispersion, uniformly stirring and carrying out enzymolysis for 1.5-2.5 hours, wherein β -amylase is added in an amount of 0.4-0.8% of the content of the substrate, adjusting the pH to 2.5-4.5, adding pectinase into the dispersion, uniformly stirring and carrying out enzymolysis for 2.0-2.5 hours at 50 +/-3 ℃, wherein the addition of the pectinase is 0.25-0.4% of the content of the substrate, adjusting the pH to 7.5-8.5, adding trypsin into the dispersion, uniformly stirring and carrying out enzymolysis for 1.5-2.5 hours at 37 +/-1 ℃, wherein the addition of the trypsin is 0.35-0.65% of the content of the substrate, and carrying out enzyme deactivation by using a high-temperature instant enzyme deactivation method after the enzymolysis is finished;
(Y5) concentration under reduced pressure: concentrating the clear liquid under reduced pressure, controlling the concentration temperature to be 70-75 ℃, controlling the vacuum degree to be-0.08-0.095 Mpa, and controlling the relative density to be 1.05-1.08 to obtain an extract;
(Y6) spray drying: and sterilizing and filtering the extract, and then spray-drying, wherein the process parameters are that the nozzle temperature is 175-182 ℃, the outlet temperature is 85-90 ℃, and the feeding speed is 2.5-3.0L/min, so as to obtain the cereal powder.
7. The method for preparing the diet composition for slimming meal replacement according to claim 5, wherein the method for preparing the diet composition for slimming meal replacement comprises preparing the composite oil microcapsule, wherein the preparing of the composite oil microcapsule comprises the steps of:
(Z1) preparing a first wall material/core material solution, namely uniformly stirring poppy seed oil and antarctic krill oil in a preset mass ratio to prepare a mixed oil core material solution, uniformly mixing red date polysaccharide, rosemary extract, gamma-cyclodextrin and sucrose fatty acid ester, adding a proper amount of water, and fully stirring and dissolving to prepare a wall material solution with the mass fraction (m/m) of 25-30%, wherein the mass ratio of the red date polysaccharide to the rosemary extract to the gamma-cyclodextrin to the sucrose fatty acid ester is 7-9: 0.4-0.6: 9-11: 0.5 to 1.5;
(Z2) embedding a layer, namely, mixing the grease core material solution and the wall material solution in the step (Z1) according to the ratio of 2-3: 3-5, emulsifying and homogenizing for 8-12 min at the rotating speed of 2500-3500 r/min by using an emulsifying homogenizer, standing for 3h, separating a water outlet layer by using an oil-water separator, discarding, and collecting an oil layer for later use;
(Z3) preparing a second wall material/core material solution, namely taking the oil layer in the step (Z2) as the second core material solution, uniformly mixing tremella polysaccharide, sodium alginate, gamma-cyclodextrin and pectin, adding a proper amount of water, fully stirring and dissolving to prepare a wall material solution with the mass fraction (m/m) of 30-35%, wherein the mass ratio of the tremella polysaccharide to the sodium alginate to the gamma-cyclodextrin to the pectin is 10-12: 0.5-1.5: 9-13: 1-3;
(Z4) two-layer embedding, i.e. mixing the second core material solution and the wall material solution in the step (Z3) according to the ratio of 1.5: mixing the raw materials according to the mass ratio of 1-2.5, and continuously stirring for 10-15 min to prepare a secondary embedding solution;
(Z5) spray drying, namely, spray drying the secondary embedding liquid in the step (Z4) to obtain the compound oil microcapsule, wherein the process parameters are that the nozzle temperature is 180-185 ℃, the outlet temperature is 85-95 ℃, and the feeding speed is 2.5-3.0L/min, and the red date polysaccharide (tremella polysaccharide) in the steps (Z1) and (Z3) can be prepared through the following steps:
(Z6) enzymolysis: taking crushed red date ultrafine powder (tremella ultrafine powder), adding water which is 15-45 times of the weight of the materials and 1.0-2.5% of pectinase, performing enzymolysis for 50-90 min at a constant temperature of 45-55 ℃, and heating to above 95 ℃ to inactivate the enzyme;
(Z7) extraction: carrying out heat preservation extraction at the temperature of 95-100 ℃, filtering by using a 500-mesh screen to obtain a red date polysaccharide (tremella polysaccharide) extracting solution, wherein the extracting times are 1-2 times, and the extracting time is 1-3 hours each time;
(Z8) ion exchange: performing impurity removal and decoloration treatment on the filtered red date polysaccharide (tremella polysaccharide) extract through an ion exchange column and an active carbon column;
(Z9) concentration in vacuo: carrying out vacuum concentration on the solution after ion exchange, wherein the concentration temperature is 65-85 ℃, and the vacuum degree is-0.075-0.095 Mpa, so as to obtain a red date polysaccharide concentrated solution (tremella polysaccharide concentrated solution), and the relative density is controlled to be 1.03-1.05;
(Z10) vacuum freeze drying: the red date polysaccharide concentrated solution (tremella polysaccharide concentrated solution) is prepared into red date polysaccharide powder (tremella polysaccharide powder) through a vacuum freeze drying technology, wherein the pre-freezing initial temperature is-38 ℃ to-48 ℃, the pre-freezing speed is 0.3-0.6 ℃/min, the pre-freezing final temperature is-75 ℃, the pressure of a drying chamber is 45-110 pa, the temperature of a heating plate is 35-45 ℃, and the drying time is 20-26 h.
8. The method for preparing the diet composition for slimming meal replacement according to claim 5, wherein the method for preparing the diet composition for slimming meal replacement comprises preparing composite traditional Chinese medicine microcapsules, wherein the method for preparing the composite traditional Chinese medicine microcapsules comprises:
supercritical CO2And (3) extraction: sieving coarse powder of cinnamon and juniper berries by a 6-8-mesh sieve, and then sieving the coarse powder with CO2Extracting by supercritical extraction (extraction temperature is 35-42 ℃, extraction pressure is 32-38 Mpa, CO is2The flow rate is 9-15 kg/h, the extraction time is 120-150 min, the separation pressure is 4-5MPa, the separation temperature is 35-40 ℃), and oily extracts of cinnamon and juniper berries are obtained through separation;
(II) carrying out microcapsule embedding integrated forming, namely weighing an appropriate amount of α -cyclodextrin, sodium alginate and silicon dioxide before the beginning of the step (I), uniformly mixing, placing the mixture at the bottom layer of a separation kettle of a supercritical extraction device for microcapsule embedding integrated forming, wherein the mass ratio of α -cyclodextrin, sodium alginate and silicon dioxide is 7-9: 1-2: 0.2-1.0, the total amount of mixed powder of the three is 5-10% of the total amount of coarse powder of cinnamon and juniper seeds, extracting grease of the cinnamon and the juniper seeds enters a preheater for heating through the top of the extraction kettle, reducing the pressure to 4-5MPa in the separation kettle, and CO is introduced into the separation kettle2After separation, the CO enters from the top side part of the separation kettle2The total storage tank is recycled, oily cinnamon and juniper berry extracts form a sinking cyclone in a separation kettle through a vortex flow guide air port, the sinking cyclone, α -cyclodextrin, sodium alginate and silicon dioxide powder are fully mixed and embedded in the separation kettle under the action of high-pressure airflow to prepare composite traditional Chinese medicine microcapsule powder, the composite traditional Chinese medicine microcapsule powder is formed in one step, the loss and the loss of functional components of an embedding object caused by a spray drying process are avoided, the process is compressed, the cost is saved, and inert gas CO is contained in the separation embedding kettle2Protecting, performing cyclone embedding at low temperature, avoiding oxidative decomposition of effective components, and making into composite Chinese medicinal microcapsuleThe pine nut is used as raw material and is processed by supercritical CO2The extract is prepared by extraction and microcapsule embedding integrated forming technology, wherein the embedding rate of functional components in the composite traditional Chinese medicine microcapsule is more than 90%, and the particle size is 100-230 microns, compared with the traditional alcohol extraction method, the cinnamon and juniper berry extract prepared by the method has the advantages that the process operation of one-step forming abandons the traditional alcohol extraction process which needs concentration and spray drying, the extraction time is greatly shortened by more than 50%, and the extraction yield is improved by more than 30%.
9. The method of preparing the diet composition for slimming meal replacement according to claim 5, wherein the method of preparing the diet composition for slimming meal replacement comprises preparing a multivitamin, wherein the method of preparing the multivitamin comprises:
(H1) sieving, namely weighing the L-sodium ascorbate and the maltodextrin in the mass fraction for later use; weighing the nicotinic acid, the vitamin A acetate, the D-calcium pantothenate, the thiamine hydrochloride, the pyridoxine hydrochloride, the riboflavin and the vitamin D according to the mass fraction3Uniformly sieving folic acid and cyanocobalamine with a disk vibrating sieve to obtain vitamin sieving powder, wherein the mesh number of the sieve is 80-100 meshes;
(H2) triple premixing, namely putting the vitamin sieving powder obtained in the step (H1) and maltodextrin with the same weight as the vitamin sieving powder into a small three-dimensional mixer for three-dimensional premixing, wherein the mixing time is 10-15 min, and the mixing frequency is 15-20 Hz; repeating the above operations twice according to an equivalent incremental method, adding maltodextrin with the same weight as the mixed powder each time for premixing, and repeating the above operations twice;
(H3) and (3) three-dimensional mixing, namely uniformly placing the triple premixed powder obtained in the step (H2), the L-sodium ascorbate and the rest maltodextrin in a three-dimensional mixer for three-dimensional mixing, wherein the mixing time is 20-35 min, and the mixing frequency is 18-25 Hz, so that the multivitamin is prepared for later use, the mixing uniformity of the effective components of the multivitamin is particularly high due to the adoption of the preparation processes of sieving, triple premixing and three-dimensional mixing, and the RSD values of the effective components obtained by sampling and measuring at different sampling points are all less than 0.6%.
10. The method of preparing the diet composition for the diet meal replacement according to claim 5, wherein the method of preparing the diet composition for the diet meal replacement comprises preparing a potato extract, wherein the method of preparing the potato extract comprises:
(K1) crushing and mixing the pulp, namely cleaning and peeling fresh potatoes, adding purified water with the weight 30-40 times that of the materials, fully stirring and crushing the materials into potato pulp, and adjusting the pH value to 4.0;
(K2) performing ultrasonic-assisted enzymolysis, namely adding pectinase accounting for 0.5-2% of the weight of the potato pulp and α -amylase accounting for 1-1.5% of the weight of the potato pulp into the potato pulp prepared in the step (K1), performing enzymolysis at a constant temperature of 45-50 ℃ for 60-90min, and improving enzymolysis efficiency by ultrasonic-assisted enzymolysis with the ultrasonic power of 100-200W;
(K3) performing centrifugal filtration, namely performing centrifugal impurity removal on the enzymolysis liquid prepared in the step (K2), keeping the centrifugal rotation speed of 13000-17000 r/min and the feeding speed of a peristaltic pump of 2.2-3.3L/min, and collecting supernatant;
(K4) ion exchange, namely, the enzymolysis supernatant fluid prepared in the step (K3) passes through an ion exchange column and an activated carbon column to be subjected to impurity removal, decoloration and deodorization treatment;
(K5) membrane filtration, namely starting membrane filtration equipment, filtering supernate by using a microporous filter membrane, wherein the thickness of the filter membrane is 120-160 mu m, the filtered particle size is 8-20 mu m, the operating pressure is 0.05-0.45 MPa, and collecting protein filter residues;
(K6) and (4) performing vacuum freeze drying, namely preparing the protein filter residue prepared in the step (K5) into a potato extract by using a vacuum freeze drying technology, wherein the pre-freezing initial temperature is-40 to-45 ℃, the pre-freezing speed is 0.3 to 0.4 ℃/min, the pre-freezing final temperature is-75 ℃, the pressure in a drying chamber is 7 to 110pa, the temperature of a heating plate is 35 to 45 ℃, and the drying time is 20 to 24 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911366214.XA CN111096416A (en) | 2019-12-26 | 2019-12-26 | Diet-depriving composition for weight-losing meal replacement and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911366214.XA CN111096416A (en) | 2019-12-26 | 2019-12-26 | Diet-depriving composition for weight-losing meal replacement and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111096416A true CN111096416A (en) | 2020-05-05 |
Family
ID=70424885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911366214.XA Pending CN111096416A (en) | 2019-12-26 | 2019-12-26 | Diet-depriving composition for weight-losing meal replacement and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111096416A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113750113A (en) * | 2020-06-01 | 2021-12-07 | 山东新时代药业有限公司 | Composition of probiotics and prebiotics and application thereof |
CN113974167A (en) * | 2021-11-10 | 2022-01-28 | 海而思(郑州)科技有限公司 | Meal replacement food and preparation method thereof |
CN117562257A (en) * | 2024-01-15 | 2024-02-20 | 北京衡美金叶营养健康科技有限公司 | High-fat low-carbon food composition and preparation method thereof |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101597332A (en) * | 2009-07-14 | 2009-12-09 | 江南大学 | A kind of preparation method of potato asparaginic acid protease inhibitors |
JP2010273552A (en) * | 2009-05-26 | 2010-12-09 | Toyo Shinyaku Co Ltd | Diet composition |
US20110003021A1 (en) * | 2009-07-01 | 2011-01-06 | Jason Christian Grovenor Halford | Composition and method for reducing food intake |
CN102687750A (en) * | 2012-06-13 | 2012-09-26 | 杭州诺伽特健康科技有限公司 | Weight losing and meal replacement protein type solid beverage |
CN104287049A (en) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | Meal replacement protein powder solid beverage for managing body weight |
CN106360233A (en) * | 2016-08-29 | 2017-02-01 | 宁波御坊堂生物科技有限公司 | Meal replacement solid drink and preparation method thereof |
CN107960664A (en) * | 2017-12-01 | 2018-04-27 | 春雨壹品(北京)国际信息科技有限公司 | A kind of nutrition fat-reduced food |
CN108142789A (en) * | 2017-11-28 | 2018-06-12 | 中国食品发酵工业研究院 | Light food nutrient breakfast powder, meal replacement powder set meal for weight-reducing and preparation method thereof |
CN108338360A (en) * | 2018-01-31 | 2018-07-31 | 陕西海斯夫生物工程有限公司 | A kind of high temperature resistant distinctive unsaturated fat acid lipid microcapsule powder and preparation method thereof |
CN108378317A (en) * | 2018-01-15 | 2018-08-10 | 北京同仁堂健康药业股份有限公司 | A kind of weight losing meal-replacing stick and preparation method thereof |
CN108450938A (en) * | 2017-02-20 | 2018-08-28 | 广州小杉健康科技有限公司 | A kind of fat reducing meal replacement powder and preparation method thereof |
CN108618126A (en) * | 2018-04-10 | 2018-10-09 | 陕西三正医用营养有限公司 | A kind of Chinese medicine compound prescription weight-reducing special diet food and preparation method thereof |
CN108618151A (en) * | 2018-04-16 | 2018-10-09 | 宁波御坊堂生物科技有限公司 | A kind of probiotic microcapsule and preparation method thereof keeping bacterial activity |
CN108703375A (en) * | 2018-04-04 | 2018-10-26 | 大连医诺生物股份有限公司 | Weight losing function food containing conjugated linoleic acid |
CN109329907A (en) * | 2018-08-23 | 2019-02-15 | 黑龙江飞鹤乳业有限公司 | A kind of nutritional meal replacement powder and preparation method thereof |
CN109601916A (en) * | 2018-12-28 | 2019-04-12 | 中泰宜佳健康科技(北京)有限责任公司 | A kind of weight losing meal-replacing composition and preparation method thereof |
CN109645500A (en) * | 2018-12-07 | 2019-04-19 | 北京康比特体育科技股份有限公司 | A kind of cereal generation meal stick and preparation method thereof for fat reducing |
CN109852477A (en) * | 2019-01-17 | 2019-06-07 | 广东聿津食品有限公司 | A kind of preparation method of cinnamon essential oil |
-
2019
- 2019-12-26 CN CN201911366214.XA patent/CN111096416A/en active Pending
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010273552A (en) * | 2009-05-26 | 2010-12-09 | Toyo Shinyaku Co Ltd | Diet composition |
US20110003021A1 (en) * | 2009-07-01 | 2011-01-06 | Jason Christian Grovenor Halford | Composition and method for reducing food intake |
CN101597332A (en) * | 2009-07-14 | 2009-12-09 | 江南大学 | A kind of preparation method of potato asparaginic acid protease inhibitors |
CN102687750A (en) * | 2012-06-13 | 2012-09-26 | 杭州诺伽特健康科技有限公司 | Weight losing and meal replacement protein type solid beverage |
CN104287049A (en) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | Meal replacement protein powder solid beverage for managing body weight |
CN106360233A (en) * | 2016-08-29 | 2017-02-01 | 宁波御坊堂生物科技有限公司 | Meal replacement solid drink and preparation method thereof |
CN108450938A (en) * | 2017-02-20 | 2018-08-28 | 广州小杉健康科技有限公司 | A kind of fat reducing meal replacement powder and preparation method thereof |
CN108142789A (en) * | 2017-11-28 | 2018-06-12 | 中国食品发酵工业研究院 | Light food nutrient breakfast powder, meal replacement powder set meal for weight-reducing and preparation method thereof |
CN107960664A (en) * | 2017-12-01 | 2018-04-27 | 春雨壹品(北京)国际信息科技有限公司 | A kind of nutrition fat-reduced food |
CN108378317A (en) * | 2018-01-15 | 2018-08-10 | 北京同仁堂健康药业股份有限公司 | A kind of weight losing meal-replacing stick and preparation method thereof |
CN108338360A (en) * | 2018-01-31 | 2018-07-31 | 陕西海斯夫生物工程有限公司 | A kind of high temperature resistant distinctive unsaturated fat acid lipid microcapsule powder and preparation method thereof |
CN108703375A (en) * | 2018-04-04 | 2018-10-26 | 大连医诺生物股份有限公司 | Weight losing function food containing conjugated linoleic acid |
CN108618126A (en) * | 2018-04-10 | 2018-10-09 | 陕西三正医用营养有限公司 | A kind of Chinese medicine compound prescription weight-reducing special diet food and preparation method thereof |
CN108618151A (en) * | 2018-04-16 | 2018-10-09 | 宁波御坊堂生物科技有限公司 | A kind of probiotic microcapsule and preparation method thereof keeping bacterial activity |
CN109329907A (en) * | 2018-08-23 | 2019-02-15 | 黑龙江飞鹤乳业有限公司 | A kind of nutritional meal replacement powder and preparation method thereof |
CN109645500A (en) * | 2018-12-07 | 2019-04-19 | 北京康比特体育科技股份有限公司 | A kind of cereal generation meal stick and preparation method thereof for fat reducing |
CN109601916A (en) * | 2018-12-28 | 2019-04-12 | 中泰宜佳健康科技(北京)有限责任公司 | A kind of weight losing meal-replacing composition and preparation method thereof |
CN109852477A (en) * | 2019-01-17 | 2019-06-07 | 广东聿津食品有限公司 | A kind of preparation method of cinnamon essential oil |
Non-Patent Citations (1)
Title |
---|
许源: "紫苏油超临界萃取及环糊精包合一体化研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑 (月刊)》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113750113A (en) * | 2020-06-01 | 2021-12-07 | 山东新时代药业有限公司 | Composition of probiotics and prebiotics and application thereof |
CN113750113B (en) * | 2020-06-01 | 2022-12-02 | 山东新时代药业有限公司 | Composition of probiotics and prebiotics and application thereof |
CN113974167A (en) * | 2021-11-10 | 2022-01-28 | 海而思(郑州)科技有限公司 | Meal replacement food and preparation method thereof |
CN117562257A (en) * | 2024-01-15 | 2024-02-20 | 北京衡美金叶营养健康科技有限公司 | High-fat low-carbon food composition and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
CN101347241B (en) | Nano functional health food and method of processing the same | |
CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
CN109123643A (en) | A kind of preparation method of cereal generation meal ball | |
CN111053190A (en) | Light-weight food composition for weight-losing meal replacement and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN104799146A (en) | Functional nutritional good composition for improving sub-health and preparation method thereof | |
CN111096416A (en) | Diet-depriving composition for weight-losing meal replacement and preparation method thereof | |
CN105942498A (en) | Functional nutritional food compounds with diabetes-treating effects and preparation methods thereof | |
CN103463457A (en) | Dendrobium officinale and hericium erinaceus compound chewable tablet and preparation method thereof | |
CN112931741A (en) | Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health | |
CN105124605A (en) | Health care chewable tablet and preparation method thereof | |
CN101766274B (en) | Antioxidant functional food composition containing bamboo-leaves flavones | |
CN110051815A (en) | A kind of auxiliary hyperglycemic food ball and preparation method thereof | |
CN109395028A (en) | A kind of Ge Jingjia ginseng wine formula and preparation method preventing, treating three high diseases | |
CN110638038A (en) | Medical formula nutritional meal replacement powder for controlling hyperglycemia and preparation method thereof | |
CN104783174A (en) | Preparation method of pure natural nutritional, immune and health solid beverage | |
KR20030053417A (en) | Health food composition which contains Saururus chinensis Baill. and others | |
CN109275906A (en) | The preparation method of one kind of multiple plant compounding anoretics | |
CN113842452A (en) | Medicine composition for treating diabetes and preparation method thereof | |
CN113812550A (en) | Ginseng and poria cocos solid beverage and preparation method thereof | |
CN107212402B (en) | Blood pressure lowering food and preparation method thereof | |
CN112690449A (en) | Cereal conditioning porridge for middle-aged and old people | |
CN110651983A (en) | High-protein nutrition powder and preparation method thereof | |
CN109043339A (en) | Promote the integration of drinking and medicinal herbs food and preparation method that human metabolism loses weight |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |